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Abstract  
This thesis describes the author’s contribution, from 1997-2017, to medicines optimisation 
through use of a person-centred care approach to pharmacy practice. It outlines the author’s 
publications in the area of pharmacy practice and older people together with copies of key 
publications and relevant authorship statements. The thesis is divided into four key themes: 
pharmacy and older people, clinical leadership, reducing preventable medicines-related 
hospital readmission and the development of a coaching approach in pharmacy practice.  
The thesis begins with describing the growth of the author’s skills as a hospital pharmacist 
working with older people, which provides the content for the first theme. This includes 
development of the author’s research skills and the start of collaboration with a cross-sector 
multidisciplinary team, led by a national leader in the care of older people.  
The second theme, of clinical leadership, incorporates the author’s role as the first consultant 
pharmacist working with older people in England and also as a pharmacist prescriber in 
intermediate and long-term care.  This includes the creation and leadership of the national 
consultant pharmacist group for England and information about pharmacist prescribing 
through publications and describes how practice focussed on what mattered to patients.  
The third theme focuses on reducing preventable medicines-related re-admissions and 
includes description of the development of the Integrated Medicines Management Service 
(IMMS), an award winning service, including delivery of person-centred consultations.  
The fourth and final theme outlines the development of a coaching approach to pharmacy 
practice including the use of health coaching. This includes development of the nationally 
utilised “Four Es” (Explore, Educate, Empower, Enable), a structured approach to person-
centred pharmacy consultations to support medication review, medicines adherence, reducing 
inappropriate polypharmacy and optimising safe deprescribing.  This section of the thesis also 
describes  collaboration with colleagues to develop the nationally recognised “patient-centred 
polypharmacy process”, joint-editing a peer-reviewed themed journal issue on deprescribing 
and devising and delivering learning events to provide pharmacy support for special 
populations.   
This thesis demonstrates that the author has contributed to the development of person-
centred care in pharmacy practice. The author’s work in this area supports medicines 
optimisation, thus improving the patient experience and the provision of safe, effective 
pharmacy services, which are embedded within everyday pharmacy practice. 
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Chapter 1 Context, Literature review, Aims and objectives 
1.1 Context for the presented work  
Evidence from the literature suggests that approximately 10% of all hospital admissions and 
re-admissions are linked to medication and up to half are considered preventable 
(Pirmohamed, et al., 2004; Leendertse, et al., 2010). Therefore, reducing preventable 
medicines-related hospital admission is a priority. This is particularly important for older 
people because of the risk of an adverse drug reaction leading to admission in this group, 
estimated to be approximately 20% (Williamson and Chopin, 1980), which is greater than the 
estimated 10 percent risk in the general population (Kongkaew et al., 2013). The literature 
suggests that specific high risk medication, non-adherence to medication and lack of 
monitoring (Howard, et al., 2006; National Institute for Health and Care Excellence, 2009)  as 
well as poor communication at care transition (Witherington, Pirzada and Avery., 2008; Royal 
Pharmaceutical Society, 2012 a,b), are key factors that influence preventable medicines-
related admissions and re-admission.  The work detailed in this thesis began while the author 
was working with older people, at the time of the publication of the National Service 
Framework (NSF) for Older People (Department of Health, 2001). Identification of the 
challenges of providing person-centred pharmaceutical care was the driving force for the 
continuing work.  
1.1.1 Career History 
The author’s career began working as a hospital pharmacist in the speciality of care of older 
people, in a North West London Hospital in the late 1980s. The author worked on wards 
serving older people and was a member of a multidisciplinary team led by Dr Michael Denham, 
past president of the British Geriatrics Society. In contrast to commonly practiced medical care 
at the time, person-centred care was practiced on these wards. Older people, an often 
vulnerable, multimorbid and sometimes ignored population, were asked about their values 
and preferences for care and involvement in decisions about their care.  The author’s career 
continued to develop within hospital pharmacy, and broadened to include working in 
medicines information with primary care as well as providing ward- based services to long stay, 
intermediate care and mental health units for older people.  
Working with older people 
It was not until the publication of the NSF for Older People in 2001 that the author had the 
opportunity to initiate development of person-centred care for pharmacy practice, working 
with the care of older people team who were based in Northwick Park Hospital in North West 
9 
 
London, UK. The author received funding in 2002, from the local primary care organisation, 
and devised and completed a study to support the role of the pharmacist within the NSF for 
Older People. This included medication history taking on admission, medication review with 
the multidisciplinary team and primary care liaison at the time of and after discharge from 
hospital. It is here that the author identified a gap in pharmacy practice at the time. The 
traditional approach to medicines-related care at the time was clinician-centred, focussing on 
the pharmaceutical and pharmacological effects of medicines, rather than the impact of 
medicines use and medicines taking on patients; a more person-centred approach. The author 
identified this as an opportunity to transfer learning from years of observing medical practice 
with older people into wider pharmacy practice, while recognising the potential benefit of 
improved pharmacy engagement with patients to support optimal benefit from medicines use 
going forward. This became a driving force for the author’s subsequent practice and research.  
Pharmacist prescribing and consultant role 
As one of the first cohort of pharmacists to qualify initially as a supplementary pharmacist 
prescriber in 2004, and then convert the qualification to independent prescribing in 2007, the 
author prescribed for older nursing home residents, working with a nurse prescriber to provide 
patient with quicker access to care through improved skill mix. The author also engaged in 
postgraduate teaching, contributing to the postgraduate master’s programme in community 
pharmacy (King’s College London) and master’s programme in pharmacy practice (London 
School of Pharmacy) as well as developing and delivering a pharmacy prescribing programme 
at King’s College London. The author was appointed to the first Consultant Pharmacist for 
Older People role in England in January 2007, founding a regional and then national group of 
Consultant Pharmacists, which the author chaired from 2008- Oct 2010 and of which the 
author is currently joint chair with Professor Nicola Stoner. 
Coaching in pharmacy practice 
Reflecting on the author’s practice experience and engaging with pharmacists working with 
older people through clinical networks and teaching, the author was aware that clinical 
pharmacy practice at the time did not include training for pharmacists in person-centred 
consultation skills.  In 2010, the author undertook coaching training to support the hospital 
pharmacy team and, following discussion with the trainers, identified an opportunity to use a 
coaching approach with patients. In order to explore these skills in a pharmacy context, the 
author then undertook further education in health coaching, later becoming a health coach 
trainer.  Following an interaction with a General Practitioner (GP) about medicines in 2011, the 
author published a personal reflection on person-centred care in relation to medicines, which 
highlighted the opportunity for pharmacists to consider a new way to consult with patients. 
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This thinking was developed through a number of work streams. The first was leading work on 
reducing preventable medicines-related re-admission where the use of health coaching was 
integrated into patient consultations during admission and before discharge. Pharmacists 
undertaking patient consultations would routinely offer solutions for the patient’s medicines-
related problems that the pharmacist identified. From 2014, pharmacists working on reducing 
preventable medicines-related re-admission were trained to use a coaching approach to 
pharmacy consultations, focussing on what the patient wanted to achieve from their 
medicines use and helping them to use their own resources to find solutions.   The approach 
was also used when referring patients to the New Medicines Service (NMS), where paper 
based referral yielded poor results, with only 1 in 65 patients referred over two months 
receiving the NMS service after hospital discharge. When a coaching approach was used in 
consultations, identifying patient goals, as well as having direct contact with community 
pharmacists, the implementation of NMS rate improved to 9/28 patients over one month 
following one telephone call (Barnett, Parmar and Ward, 2013a,b).   The service to reduce 
preventable medicines-related re-admission was recognised through a Health Service Journal 
Value in Healthcare Award in 2015.  Following the delivery of health coaching skill 
development to pharmacy teams in hospital, community and primary care practice, the author 
secured a £20,000 charitable grant from the local organisation. Health coaching training was 
then delivered during 2016 to pharmacy and other staff by the author and colleagues, to 
support optimising medicines-related consultations within the author’s organisation. The work 
on reducing preventable medicines related re-admission including coaching approach to 
consultations was presented at the British Geriatric Society Spring conference of 2016 and the 
abstract was published in Age and Ageing. 
A coaching approach to medicines adherence 
With the publication of the NICE adherence guidance in 2009, the author reflected on the 
practical and perceptual approaches to adherence and how delivering person-centred 
consultations using coaching approach could support better outcomes from medicines. The 
author published an article on the challenge of medicines adherence and in 2012, using the 
concept of health coaching to promote person-centred consultations; the author developed 
the “four Es” (Explore, Educate, Empower, Enable), a structure for short, medicines-related 
consultations applicable to the pharmacy context. The four Es structure was presented at 
conferences and meetings throughout the UK. Working with the Centre for Postgraduate 
Pharmacy Education (CPPE) and the Department of Health to spread the learning nationally, 
the author contributed a chapter on health coaching in pharmacy practice. This included 
contributing to the national Consultation Skills for Pharmacy Practice programme, published in 
February 2014. The Four Es approach is now taught as part of a number of undergraduate 
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university courses in the UK. Further collaboration with colleagues with expertise in person-
centred pharmacy services and with pharmacy education and consultation led to additional 
publications. The author recognised that medicines adherence is an important issue for many 
clinicians and, in collaboration with a cognitive behavioural therapist who was also a 
pharmacist, published guidance on person-centred consultations for nurses working with 
cardiology patients.  To support the spread of the medicines–related person-centred 
consultations concept, the author has made recent contributions to two textbooks.  
Polypharmacy and deprescribing 
With the increasing concern about medicines wastage and negative consequences of 
inappropriate use of too many medicines (inappropriate polypharmacy), the author identified 
that person-centred consultations were of particular value in managing polypharmacy and 
deprescribing. In 2013, collaborating with a national leader in primary care pharmacy and 
older people, the author published a review of the challenge of polypharmacy, identifying a 
gap in patient focus from existing polypharmacy support documents and approaches.  This led 
to development of a person-centred consultation framework for polypharmacy, which was 
subsequently published in 2015 in a peer reviewed journal. Other collaborations included 
publication with multidisciplinary colleagues about the need for empathy in pharmacy 
consultations to support medicines optimisation.  
In 2015, the author was commissioned by CPPE to produce videos on the person-centred 
polypharmacy consultation framework for the CPPE website “media wall” as well as 
contributing and reviewing the CPPE polypharmacy learning programme (Centre for Pharmacy 
Postgraduate Education, 2016a,b). The author delivered a keynote address on this work at a 
joint RPS and Royal College of General Practitioners conference on polypharmacy in April 2016.  
Having been invited to be one of the only two pharmacist members of the NICE multimorbidity 
guideline group, the author contributed to this person-centred practice guideline, published in 
September 2016.  
Continuing to promote person-centred care through work as RPS representative for older 
people, the author has appeared on national television, radio and in print. In addition, having 
been appointed Visiting Professor in the Institute of Pharmaceutical Science at King’s College 
London in April 2015, the author teaches clinicians nationally and internationally in the use of 
health coaching, focusing on a person-centred approach in pharmacy practice. The author has 
published 53 publications which have been cited 258 times with an H index of 6 (Google 
Scholar accessed 25 May 2017). 
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Figure 1 illustrates the author’s 258 citations by year from 1997 to 2017 
Figure 1 Author’s citations by year (25 May 2017) 
 
1.2 Literature review  
In preparing this thesis, a literature review was undertaken to identify published national 
policy in England and the UK, professional guidance and national or learned reports as the 
primary evidence source. This evidence provides background to understanding the pharmacy 
context at the time and how this influenced the author’s work in development of person-
centred care within pharmacy practice. 
1.2.1 Literature review methods  
A initial review of the literature using the terms “pharmacy practice” and “person-centred 
care” using related keywords and synonyms was undertaken in Medline, Embase, Social 
Sciences, International Pharmaceutical Abstracts (IPA), social policy and practice, PsychInfo 
and Cinahl from 1997 to 2017 (see search strategy appendix 1). Searches combining these 
terms with “older people” and synonyms were undertaken to identify policy relating to this 
patient group. The databases were chosen to optimise literature capture relating to person-
centred and pharmacy practice. The search included some international literature, focussing 
on literature from the United States, Australia, Canada and the Netherlands where, despite 
operating within different health care systems, there are similarities to UK pharmacy practice  
(The Royal Pharmaceutical Society England, 2013). The results of these searches did not 
include relevant UK guidance or policy documents and the searches were therefore expanded 
to include Department of Health (DH) and RPS websites, as well as other professional body and 
health organisation websites. Contact was also made with specific organisations, such as the 
Royal College of Physicians, to obtain policy documents not available online or through 
libraries. These documents were reviewed and references from the publications, which 
included literature reviews and peer-reviewed papers, were obtained. Other papers from the 
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author’s day-to-day work, identified as having a significant impact on practice, were included. 
Leaders in UK pharmacy policy development and person-centred care were consulted in order 
to support identification of key literature.  International reports and guidance from countries 
that lead in pharmacy development, such as Australia, Canada and the United States of 
America (US), were identified through professional organisation websites and were included 
where relevant.  
1.2.2 Literature search results 
1.2.2.1 Patient, Person or People centred care in health 
Person-centred care incorporates use of clinician skills, evidence-based knowledge and patient 
perspective to provide personalised, co-ordinated care which enables people to make the 
most of their lives (Health Foundation, 2014).  International policy (World Health Organisation, 
2007) and guidance produced by professional bodies (Nursing and Midwifery Council, 2015;  
General Medical Council, 2013) has highlighted the need to move from health-care 
professional centred models of care towards a person-centred model. Guidance from the 
General Pharmaceutical Council (GPhC) applies this to pharmacy practice (General 
Pharmaceutical Council, 2017), with “provide person-centred care” as being the first of the 
recently published nine standards.  
Terminology around moving the focus of care from the health provider to the health-care 
recipient appears in various forms. People who register for or access health-care are defined as 
patients (Oxford University Press, 2017)   and the use of the term “patient-centred” care gained 
popularity in the early 2000s (World Health Organisation , 2005). The concept of “health-care 
recipient” focussed care has broadened over time. Both “person- centred”  (Health 
Foundation, 2014) care and “people-centred” care (World Health Organisation, 2007) are 
terms used to reflect the concept that while patients are people (individuals) receiving health-
care, they have lives outside health-care, within families and communities (World Health 
Organisation, 2007). The author’s work relates to developing and embedding this concept in 
pharmacy practice, moving from clinician-centred care, through patient-centred care, towards 
person-centred care, which is now the accepted term in health-care (Care Quality Commission, 
2014; Health Foundation, 2014;   Royal College of General Practitioners, 2014; National 
Institute for Health and Care Excellence, 2016; General Pharmaceutical Council, 2017).  
Person-centred care refers to the care which focuses on an individual receiving health-care 
(patient), recognising the person’s expertise, which includes living with their condition and 
living their lives with their families and communities. It takes account of their values, 
preferences and needs to shape and co-create care that optimises their health in the context 
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of their lives. In recent years, guidance for pharmacy (Royal Pharmaceutical Society and 
General Pharmaceutical Council, 2014; Royal Pharmaceutical Society Wales, 2014; King’s Fund, 
2015) has placed a strong emphasis on patient-centred care including the link with  
professionalism  (General Pharmaceutical Council, 2015). The term person-centred care has 
been applied in pharmacy when working with patient groups  (Royal Pharmaceutical Society 
and National Voices, 2015). In this thesis, the term “person-centred care” is preferred; 
however, the term “patient-centred care” is applied when the term was specifically used in the 
literature.  
 1.2.2.2 Person-centred care: empowering and involving people in their care 
In the UK, there has been a social change as people want to have more control of their health. 
One example contributing to this is the increase in number of over-the-counter medicines, 
with the UK leading Europe on reclassification (Kelly, 2013) alongside a drive to encourage the 
public to seek pharmacist advice about managing their own conditions. The importance of self-
management and self-care was reflected in the NHS Plan (Department of Health, 2000a), 
created following public consultation. The NHS plan highlights the public desire for high-quality 
care centred on patients and identified disempowerment of patients as an issue to be 
addressed (Department of Health, 2008). “High quality care for all”, also known as the “Darzi 
review”, included safety, effectiveness and patient experience as the criteria for provision of 
high-quality services. The consultation and government response “liberating the NHS: no 
decision about me without me” (Department of Health 2012) highlighted the appetite at policy 
level for a culture change that delivers patient involvement at the heart of NHS practice. This 
was further developed in the NHS England document  “Five year forward view” (Department of 
Health, 2014), which introduced the idea of offering patients the opportunity to be more 
informed and involved in their care, promoting prevention of illness and supported self-care. 
This was important in changing the traditional boundaries between patients and health-care 
professionals to promote collaborative working.  
There has been a slow, steady and sustained drive in professional policy and leadership 
towards increasing self-management and empowering patients to work in partnership with 
clinicians, (Health Foundation, 2013; All Party Parliamentary Groups on Global Health, 2014; 
Department of Health, 2014; European Commission, 2014; Health Foundation, 2014; King’s 
Fund, 2014; Royal Pharmaceutical Society Wales, 2014; Department of Health, 2017;) 
supported in pharmacy by continuing professional education (Centre for Postgraduate 
Pharmacy Education, 2011). Patients are encouraged to be active participants in care rather 
than the passive recipients (Coulter and Collins, 2011). Patient activation (Hibbard and Gilburt, 
2014), which supports person-centred care, is being adopted within the NHS and licences to 
use the patient activation measure have been purchased for NHS use in England.  In addition 
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behavioural techniques have been introduced within clinical practice to support improved 
adherence to treatment, including medicines. This is being promoted in national policy 
(Department of Health, 2014) supported by emerging evidence (Rollnick, et al., 2010; Health 
Education England, 2015).  
1.2.2.3 Pharmaceutical care and pharmacy practice 
In describing pharmacy practice, work in community, hospital, industry and academic 
disciplines account for the majority of pharmacy practice in the UK. While this thesis primarily 
focuses on patient-facing pharmacy practice in a hospital setting, work from the author’s 
experience in intermediate (six week in-patient stay), long term bedded units, in primary care 
with GPs, community matrons and community pharmacists is also included. 
The author’s work utilises the concept of pharmaceutical care to underpin pharmacy practice. 
The World Health Organisation uses the term pharmaceutical care in relation to the role of 
pharmacists in various settings appropriate to different geographies (World Health 
Organisation, 1994).  The widely accepted definition of pharmaceutical care, brought forward 
by Helper and Strand (Hepler and Strand, 1990) is ‘‘Pharmaceutical care is the responsible 
provision of drug therapy for the purpose of achieving definite outcomes that improve a 
patient’s quality of life’’. Whilst the concept of pharmaceutical care was proposed in the US, 
which operates a different health system to the UK (Weekes, 2014), there are parallels in the 
provision of clinical pharmacy services, for example review of medication records on admission 
to hospital, optimising pharmaceutical formulation and working with other health-care 
professionals to improve medicines-related treatment for patients.  The definition has been 
adopted and expanded in Europe and internationally (American Society of Hospital 
Pharmacists, 1993; United Kingdom Clinical Pharmacy Association, 1996; Wiedenmayer, et al., 
2006; European Directorate for the Quality of Medicines and Health Care, 2012).   
For the purposes of this thesis, the terms “medicine or medicines” are used in relation to drugs 
for therapeutic use and “medication” is used in relation to specific activities, such as 
medication review. The principle of provision of medicines-related care for patients was 
introduced in the UK in a report by the Audit Commission (2001). This report used the term 
“medicines management” to refer to the choice, purchase, and provision, prescribing, 
administering and reviewing of medicines to produce “informed and desired outcomes of 
patient care”.  However, it was the advent of the concept of “medicines optimisation” (Picton 
and Wright, 2013; Department of Health, 2014a; National Institute of Health and Care 
Excellence, 2015) which highlighted the importance of person-centred care in pharmacy. 
Medicines optimisation focuses on the interactions between clinician and patient about 
medicines, which relates to patient experience, safety and evidence based practice, embedded 
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within everyday pharmacy practice. The concept of medicines optimisation, in relation to 
patient-facing pharmacy practice, will be used in this thesis to describe the journey within 
hospital pharmacy practice towards a person-centred approach to pharmacy practice.  
1.2.2.4 Pharmacy policy and practice 
Pharmacy contributes to provision of health-care through safe provision of high quality 
medicines and optimising the use of medicines to improve health. Policy and guidance 
produced by the World Health Organisation in 1997 (World Health Organisation, 1997), UK 
government through Department of Health (Department of Health, 2006), as well as other 
groups (Local Government Association, 2013; Royal Pharmaceutical Society England, 2013) 
describe the breadth of the pharmacist’s role. Pharmacists now serve and support patients in a 
variety of health-care settings including hospital, general practice and care homes as well as 
continuing to provide services on the high street. 
In a UK hospital setting, the move of hospital pharmacy services from a dispensary-based 
setting to in-patient wards (Baker, 1967 ) heralded the beginning of the expansion of the 
pharmacist’s role from a supply function to include provision of clinical and specialist 
pharmacy services.  In 1995, the Royal Pharmaceutical Society of Great Britain (RPSGB) 
published “Pharmacy in a new age” (PIANA), which was summarised by Professor Marcus 
Longley (Longley, 2006)  as a programme designed to encourage the pharmacy profession to 
contribute to the wider health-care team through optimising medicine use. Pharmacy services 
had been highlighted as part of the Department of Health NHS plan in 2000 (Department of 
Health, 2000). In a separate, related document, entitled “Pharmacy in the future: 
implementing the NHS Plan” pharmacy specific guidance (Department of Health, 2000a) was 
published. The stated intention for pharmacists in this document was to “spend more time 
focussing on individual patient’s clinical needs” and to help patients to get the most from their 
medicines. “Pharmacy in the Future” highlighted the importance of self-care and reinforced 
the theme, from the NHS plan, of empowering patients to take an active role in managing their 
own care. While the aims were laudable, pharmacy practice appeared slow to take up the 
recommendations and it was a paper from 2005, commonly known as the “HOMER” (HOme-
based MEdication Review) trial (Holland, et al., 2005), that raised questions about pharmacist 
skills in the context of providing individualised, person-centred support for safe, effective 
medicines use as part of the wider health-care team.  
 
The results of the HOMER trial showed an increase in hospital admissions following medication 
review visits by pharmacists to patients’ homes. The authors of the paper suggested that the 
visits may have caused patients to increase their focus on health problems or may have 
identified problems that required GP or hospital support. It has also been suggested that this 
17 
 
paper demonstrated a need to improve pharmacists’ consultation skills (Wright, 2016). The 
need for good consultations skills was brought clearly into focus with the introduction of the 
pharmacist prescribing role (UK Government, 2001; Department of Health, 2006) alongside the 
continuing development of patient-facing clinical pharmacy roles in hospital and general 
practice.  
The RPS facilitated television coverage of a “scare story”, about a sleeping pills being linked to 
increased risk of death, which the author presented (Barnett, 2012a). This not only developed 
the author’s understanding of a patient perspective on medicines but also put into context the 
importance of person-centred care in safe, effective use of medicines. However, it was the 
report of the Francis Inquiry (Francis, 2013) in February 2013, following the distressing events 
at Mid Staffordshire NHS Trust that brought person-centred care sharply into focus. This report 
called on all health-care providers to make more effort to find out what patients want and 
need, and for health-care professionals to deliver care consistently, compassionately and 
safely. The Francis report stated, in the section 1.121 of the executive summary, that putting 
patients first was a key theme for improvement. It is noteworthy that there was no explicit 
mention of the pharmacy service in the report, which may lead the reader to believe that the 
report does not apply to pharmacy services. However, it has been suggested that the lack of 
investment in the pharmacy service at Mid Staffordshire NHS Trust, with “worse than 
expected” clinical pharmacy time available, may have resulted in a more supply-orientated 
service with little patient contact (Colquhoun, 2013).    
Following the Francis Inquiry, the professional body for pharmacy, the “Now or Never” report  
was produced by RPS (Smith, Picton and Dayan, 2013) calling for the pharmacy profession to 
focus on the needs of patients. This recommendation was incorporated into the RPS 2013 
Medicines optimisation guidance (Picton and Wright, 2013) and an increase in clinical 
pharmacy patient-facing time has been highlighted in the recent review of hospital pharmacy 
by Lord Carter of Coles (Winter and Adcock, 2016) . The professional regulator for pharmacy 
highlighted patient-centred care in its review of standards of conduct, ethics and performance 
(General Pharmaceutical Council, 2015).  
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1.3 Structure and outline of thesis  
1.3.1 Iterations of structure 
The structure for this thesis was originally planned to present the reader with a chronological 
review of the author’s work (appendix 2, iteration 1). This was developed along the lines of 
themes following dialogue with a pharmacy research colleague (appendix 2, iteration 2). The 
themed approach aligned the author’s publications with the literature published by others in 
the field. A review of the requirements of this PhD with a colleague who had recently 
undertaken a PhD in another area of pharmacy practice led to the development of the grid 
used in the third iteration (appendix 2, iteration 3). From this, and after discussion with the 
author’s supervisors, a modified structure was developed to show development of the various 
work streams (Appendix 2, iteration 4). A review of a health-related PhD by publication further 
informed development of the structure (appendix 2, iteration 5) and this was finalised 
following discussion with a former pharmaceutical industry project manager (appendix 2, 
iteration 6). 
Table 1 overleaf summarises the structure of Chapters 1-5 of this thesis. It divides the author’s 
work into the primary themes of the research from 1997-2017 and provides a brief narrative, 
in note form, of how the work fits together. Figure 2 provides further detail of the content.
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Table 1 Structure of thesis with outline content and themes 
Chapter 1 Chapter 2 
 
Chapter 3 
 
Chapter 4 
 
Chapter 5 
 
Introduction: Methodology: Development: 
Themes 
Older people, 
Leadership 
Implementation:  
Themes  
Integrated medicines 
management service, coaching 
approach to consultations 
Impact and summary: 
Literature 
search for 
policy context 
and guidance 
for person- 
centred care 
and 
pharmacy 
practice. 
Include 
literature 
from 
pharmacy 
profession, 
national and 
international 
sources.  
 
Development 
of author’s 
work through 
pharmacy 
practice with 
older people 
in hospital 
and link with 
person-
centred care 
through a 
coaching 
approach to 
consultations. 
  
Aims and 
objectives. 
Rationale for 
methods chosen. 
 
Examples of 
usage in author’s 
work.  
 
Methods: to 
include 
information on: 
 
Action research 
Document 
analysis 
Dialogue  
Collaborative 
Praxis 
Quantitative 
studies (pilots). 
Describe skill 
development in 
areas of 
 
Clinical work with 
older people, 
medicines 
review, 
compliance aids, 
self-medication 
in hospital, long 
stay and 
intermediate 
care settings. 
 
 
Leadership in 
both the  
Consultant role 
and as a 
pharmacist 
Prescriber.  
 
Comment on 
Challenges from 
other published 
work eg. benefit 
of medicines 
review 
questioned. 
 
Outline local and national 
implementation 
 
Local:  
Supporting patients at risk of 
preventable medicines-related 
re-admission. 
 
Development of IMMS and 
integration of the coaching 
approach. 
 
National :  
Coaching (behavioural) 
approach to supporting 
medicines adherence. 
 
Coaching approach to 
consultations including 
publications, collaboration, 
teaching and national 
contributions,  
Empathy in pharmacy practice,  
Polypharmacy and 
deprescribing. 
 
Combining clinical, 
communication and leadership 
and education to develop a 
person-centred (coaching) 
approach to management of 
polypharmacy and 
deprescribing, using multiple 
health disciplines and 
collaboration outside health to 
achieve wide access. 
Evidence of impact: 
 
Local: IMMS and cross-
site development of 
PICS. 
 
National: contribution 
to: 
DH, NICE, CPPE and RPS 
publications and 
guidance. 
 
National/international 
presentations at 
conferences.   
 
Limitations 
The variety of 
behavioural 
approaches, how 
studies could have 
been improved. 
  
Potential future work: 
Validation cross-site of 
PICS 
 validation of coaching 
approach and 
polypharmacy process.  
Develop work on 
deprescribing and the 
law.  
 
Abbreviations: Integrated medicines management service (IMMS), Pharmacy Integrated Care Service (PICS).  
Department of Health (DH), National Institute for Health and Care Excellence (NICE), Centre for Pharmacy 
Postgraduate Education (CPPE), Royal Pharmaceutical Society (RPS) 
 
In order to understand the relationship between the elements within the themes of the 
author’s work which formed the structure of this thesis, a more detailed analysis of each 
theme was required. In addition, it was helpful to consider these elements in relation to the 
timeline of the various aspects of the work contained in the thesis, including key areas of 
content and publication. Figure 2 provides a diagrammatic representation of the elements 
within the key themes with the unifying theme being improving patient care within pharmacy 
practice. It is important to note that some areas of publication, which formed part of the 
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development of the author’s overall work, are now less relevant to the author’s practice and 
are therefore not being actively pursued.  
 
Figure 2 Relationship between areas of publication and content of the author’s work to person-
centred care in pharmacy practice with timeline. 
     
 
 
 
*Integrated Medicines Management Service (IMMS), now known as Pharmacy Integrated Care 
Service (PICS)   Area of practice not currently pursued. 
 
As outlined in table 2, this thesis describes a mixed-method research, undertaken in the 
author’s practice environment, to advance person-centred care and medicines optimisation. 
Initially working with older people, the author used policy and guidance, as well as the 
evidence base, to develop practice linked to a variety of work streams. This is illustrated in 
Person 
centred 
care in 
pharmacy 
practice 
Over-the-
counter, 
high risk 
medicines,  
Medication 
review 
Adherence, 
compliance 
aids, self 
medication 
Older 
people 
Pharmacy 
practice   
Leadership 
through 
consultant 
experience 
Health 
Coaching 
Empathy in 
consultations 
Poly-
pharmacy 
process 
 
Prescribing IMMS* Transfer of 
care  
Commun-
icating in 
pharmacy 
settings 
Deprescribing 
2007 
1997 
2017 
Timeline 
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Figure 3 which summarises the overall themes of the author’s work as they relate to the 
patient, as part of improving person-centred care in pharmacy practice.   
  
Figure 3 Illustration of aspects of the author’s work in relation to the patient 
 
 
 
*Integrated Medicines Management Service (IMMS), now known as Pharmacy Integrated Care 
Service (PICS) 
 
Figure 3 shows the patient at the centre of care and as the reader moves outwards from the 
centre, the influences on the author’s interaction with the patient are shown. For example, the 
author’s environment influenced the author’s pharmacy practice. The choice of a mixed 
methods approach was influenced by the author’s environment. National policy, person-
centred care, medicines optimisation and work with older people all influenced the mixed 
methods research undertaken. Finally, all the elements shown in the outermost ring of the 
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diagram were part of four broader categories illustrated although, in reality, there is overlap 
between areas. Another representation would be to view this in three dimensions as an 
umbrella, where the patient is the central spine of the umbrella and the outer elements are 
the tips of the spokes. 
 
In summary, the author’s work in this thesis should be viewed in the context of overall 
medicines optimisation as defined by the Royal Pharmaceutical Society (RPS) (Picton and 
Wright, 2013). The author’s work has contributed to medicines optimisation through 
developing a person-centred approach to consultations in pharmacy practice. This is 
particularly evident within both the local development and implementation of IMMS and 
though local and national promotion of a coaching approach to medicines-related patient 
consultations. As well as supporting safe and efficacious use of medicines and helping 
practitioners to develop understanding of the patient’s experience. Both local development of 
IMMS and the wider use of a coaching approach to consultations are important contributions 
to embedding medicines optimisation in every day pharmacy practice. Figure 4 illustrates the 
link between the author’s work and medicines optimisation in hospital-based pharmacy 
practice, working with older people. The author developed and integrated a coaching 
approach to pharmacy consultations into pharmacy practice, contributing to reducing 
preventable medicines-related hospital admission. 
Figure 4 Integration of person-centred care in pharmacy practice with medicines optimisation 
 
 
 
Medicines 
optimisation 
Aim to understand 
the patient’s 
experience 
Evidence base 
choice of 
medicines 
Ensure medicines 
use is as safe as 
possible 
Make medicines 
optimisation part 
of routine practice 
A coaching approach 
to pharmacy 
consultations 
Reducing 
preventable 
medicines-related 
hospital readmission 
 
Improving pharmacy 
practice for older 
people 
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1.3.2 Outline of thesis 
The thesis, in its structure, illustrates the growth of the author’s contribution from 1997 to 
2017 to the provision of person-centred care in pharmacy practice within a National Health 
Service (NHS) hospital setting in England. Chapter 1 of this thesis describes the author’s career 
history, presents a literature review of policy relevant to person-centred care in pharmacy 
practice to provide rationale and justification for the author’s work.  This is followed by an 
explanation of iterations for the structure of the thesis to provide the reader with an insight 
into the development of the thesis.  
The methods used in the author’s publications are outlined in Chapter 2, identifying examples 
of publications in which specific methods were used. The majority of methods used were 
qualitative, based on action research methods, and included praxis, document analysis, 
dialogue and collaborative methods. A small number of quantitative studies were also 
undertaken. A brief outline of the methods are included to illustrate the process undertaken, 
relevance to the overall programme of work and how they fitted together in the development 
of person-centred care in pharmacy practice. Details of methods used can be found within the 
individual publications, some of which are included in Chapter 9 of this thesis. 
 Chapter 3 describes the author’s work to support older people in hospital and the author’s 
leadership skill development. This includes information about the author as an early adopter of 
pharmacist prescribing and pioneer of the consultant pharmacist role, a role designed to 
support growth of pharmacy professionals as senior practice-based leaders of the profession, 
contributing to education and research. 
 Chapter 4 describes the implementation of person-centred care in pharmacy practice, through 
establishment of IMMS at the author’s local hospital. This chapter includes a narrative on the 
use of health coaching in consultations, initially to improve medicine adherence, later 
developing models to optimise medicines for patients through managing polypharmacy and 
deprescribing on national level. The impact of the author’s work in each area of development 
and implementation is included as part of these two chapters.  
Chapter 5 summarises the author’s contributions to developing person-centred care in 
pharmacy practice and describes limitations to the work. This chapter includes a description of 
the impact of the author’s work promoting change in pharmacy consultations with patients, 
which includes development of pharmacy services for patients at risk of preventable 
medicines-related re-admission.  This chapter includes recommendations for future practice in 
the areas of older people, person-centred pharmacy consultations, integrated medicines 
management service and professional leadership. 
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Chapters 6 and 7 provide the references and appendices respectively referred to in Chapters 1-
5. Chapter 8 lists authorship statements and confirmatory emails for papers which the author 
of this thesis contributed to, but was not listed as first author, and were referred to within this 
thesis. Approximate percentages of the author’s contribution are provided in the main body of 
the thesis (Chapters 2-5).  The final chapter, chapter 9, concludes the author’s key publications 
arranged in the order of the chapters from Chapters 1-5, including links to non-print media. 
While the author has attempted to divide Chapters 1-5 of the thesis into defined sections, the 
content is sometimes briefly repeated as a number of elements are necessarily interrelated. 
While convention dictates that abbreviations are explained the first time they are used, the 
author has repeated writing abbreviations out in full only where it is considered helpful to the 
reader. For reasons of clarity, references in the text include up to 3 author names, using “et 
al.,” for more than three authors.  
 The thesis in its structure will describe the key elements of the author’s practice, developed 
over 20 years, and how they are unified under the theme of person-centred care in pharmacy 
practice. It will also describe the local and national implementation of the key workstreams. 
Figure 5 summarises the key content covered by this thesis. 
Figure 5 Outline of this thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy practice 
National 
implementation: 
Consultation skills, 
polypharmacy process 
Coaching 
approach 
Local implementation: 
Integrated medicines 
management service 
Person-centred care Older people 
Clinical 
leadership 
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1.4: Aims and objectives 
1.4.1 Development of the author’s work 
As previously explained, the overarching aim of the author’s published work was to develop 
person-centred care as part of pharmacy practice. Research between 1997 and 2007 was 
initially undertaken after learning about the clinical contribution of pharmacists working with 
older people as illustrated in Figure 2. The author observed that practices from other health 
disciplines could improve the person-centredness of pharmacy-related health-care. 
Consultation with colleagues, within and outside the pharmacy profession, during that time 
and later fostered a shared understanding of the context of the pharmacy practice in relation 
to care of older people. National guidance, such as the NSF for Older People (Department of 
Health, 2001) created the bridge between current and potential future practice. Leadership in 
prescribing pharmacy practice between 2001 and 2011, and in consultant practice from 2007 
onwards, improved the author’s skills in spreading good practice widely and these skills 
contributed to greater impact of the work that followed. Ongoing dialogue with pharmacy and 
health-care leaders from 2005 onwards led to more collaboration to improve person-centred 
pharmacy practice in the area of medicines adherence, hospital based pharmacy services for 
people at risk of preventable medicines-related re-admission, polypharmacy and 
deprescribing. The strategy of publication focussed mainly on widely-read pharmacy journals, 
some of which were peer- reviewed, on other health professional-focussed journals as well as 
published work available through open-access health-related websites (NHS Specialist 
Pharmacy Service, 2017;  Barnett, 2016; Centre for Pharmacy Postgraduate Education, 2014). 
This strategy (see chapter 2, section 2.3) was developed to maximise exposure of both evolving 
concepts and practice to the relevant audience. 
A mixed methods approach, described in chapter 2, was used for development of this work. 
The various methods chosen reflected the author’s interest in developing practice through 
dialogue and collaboration with pharmacy, policy and clinical leaders. These methods, 
together with methods supporting innovation through iterative change, were used to influence 
strategic direction and operational change in practice. 
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1.4.2 Aim 
The aim of this thesis is to describe how the author’s work from 1997 to 2017 has interpreted, 
and later influenced, national policy and professional guidance in developing person-centred 
care in pharmacy practice. 
1.4.3 Objectives:  
To describe the contribution of the author’s work to: 
1. Pharmacy practice in the area of older people.  
2. Development of author’s leadership role towards implementation of person-centred in 
pharmacy practice. 
3. Advancement of person-centred care in pharmacy practice on a local level, including 
reducing preventable medicines-related re-admission.  
4. Establishment of a “coaching” approach to pharmacy consultations and medicines 
adherence. 
5.  Development of medication review in relation to optimising polypharmacy and 
deprescribing. 
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Chapter 2 Methodology 
The choice of methods used in the author’s publications, undertaken as part of this thesis, took 
account of the strategic and operational aspects of the change required to implement person-
centred care in pharmacy practice. The work undertaken was relevant to the pharmacy 
services practiced at the time, for example, a review of the way pharmacy was practiced for 
older people was written at a time when national directives began to highlight older people as 
having increased medicines-related risks. Consideration of this aspect of care for older people 
helped to develop person-centred care in pharmacy practice appropriate to the context of 
practice in which the work was being undertaken. This chapter describes the rationale for the 
chosen methodological approach and outlines the methods used briefly, given the constraints 
of the introductory section. It will be shown that, as the work was developmental and practice-
based, mixed methods and a mainly qualitative approach would most closely address the 
issues in question. The approach involved action research, including dialogic and collaborative 
methods, as well as document analysis. Small scale and pilot quantitative studies were 
included where appropriate to the action research themes. This chapter includes a section on 
the publication strategy as this was part of the method used to demonstrate the development 
of, and describe the author’s impact on, person-centred care in pharmacy practice. 
2.1 Methodology of the thesis and outline of methods in research 
publications 
Action research focuses on resolving specific practical issues and, for this work, involved 
working with colleagues all of whom were involved in the process of change towards 
improvement (Waterman et al., 2001; Given, 2008 pp. 4). The processes used were dynamic 
and iterative. Knowledge was gained through reflection and challenge of practice in pursuit of 
improvement and further action. Although most of the author’s studies utilised qualitative 
methods, some small scale and pilot quantitative studies were required for the practice 
element of the work. These are allowed for within the action research methodology, which 
encompasses both qualitative and quantitative work (Waterman et al., 2001 pp.11). The 
cyclical nature of action research supports continued learning and is helpful in translating 
strategic concepts for change and improvement into pharmacy practice. This method is related 
to Plan Do Study Act (PDSA) cycles (Ranasinghe and Miller, 2007) and the “action effect 
method” (Reed et al., 2014) used in the successful Collaboration for Leadership in Applied 
Health Research and Care (CLAHRC) projects in the UK. The combination of collaborative and 
iterative methods encouraged deepening of the author’s understanding of key issues and 
supported work towards providing practical solutions. The approach is potentially inductive as 
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the author generated new ideas from observations as part of the action research, rather than 
work being underpinned by a hypothesis. 
Dialogic and collaborative methods were used to optimise input from expert colleagues, 
generating ideas for practice from conversations and collaborative writing (Paulus, Woodside 
and Zeigler 2008). This thesis also contains some work which includes elements of praxis, 
recognising the philosophy that underpinned the author’s work. Dialogue supported the aim of 
this thesis as development of ideas occurred through engagement of the author with 
colleagues (Costantino, 2012) and patients. Dialogic inquiry is utilised in educational research 
(Haneda, 2014) between students and teachers. However, it also applicable as a method for 
colleagues to work together in a dialogic collaborative process to address areas of interest to 
the collaborators and develop ideas to further their joint interests (Paulus, Woodside and 
Zeigler, 2008). The author’s approach also includes an element of praxis as the author’s raison 
d’être, reflected in many of the author’s publications, was to do what was “right” in service of 
patients. The author engaged both as practitioner and thinker in developing a process towards 
improving care, which included a commitment to make the best judgement about how to act 
or progress the work with the ultimate aim of improving the patient’s quality of life. This forms 
an important part of action research, where the action, rather than being a simple activity, is 
creative, collaborative and moving towards improvement or the benefit of the patient (Smith, 
1999, 2011). Some of the work included elements of document analysis (Wharton, 2011) 
where policy and guidance was used to influence development of the work.  This mixed 
method approach, as described above, most closely meets the research aims and objectives. 
2.2 Methods 
Methods used within this thesis were mainly action research methods, including collaborative 
research and dialogic methods. Some elements from document analysis and praxis were 
included as well as a small number of quantitative studies. While the methods chosen could 
classify broadly as qualitatitive, the work itself does not create a theory, such as in grounded 
theory (Glaser and Strauss, 1967), which uses narrative and coding to develop themes. In 
addition, the author was part of the systems being studied, rather than being outside the 
systems and used the research process to learn and then modify the intervention for 
improvement in the next iteration (Dick and Swepson, 2013).  The rationale for choice of 
methods and features of the methods is described in the paragraphs below. 
2.2.1 Action research 
This method was used as both the cyclic nature of the work and the relationship between the 
researcher and collaborators, which are key features of action research (Waterman et al., 
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2001), were paramount in developing effective outcomes.  Methods included exploration, 
understanding the problem/situation and plans for intervention, with or without undertaking 
the intervention. Exploration to understand a problem (research) was followed by plans for a 
pragmatic intervention (action) which usually included observation of existing practice. The 
intervention was then carried out, followed by more exploration to understand results and 
changes. This is a cyclic approach where iterative changes are made each cycle until a 
sufficient understanding or valid intervention or solution is reached. This may be described 
more appropriately as a “spiral” approach which describes the continuous development and 
improvement, rather than a cycle which returns to the start. Examples of this from the 
author’s work include the development of IMMS, initially with a presentation at the British 
Pharmaceutical Conference in 2009 (Athwal, Barnett and Rosenbloom, 2009), to which the 
author contributed 25%, followed by Barnett, Athwal and Rosenbloom (2011). Other 
publications (Barnett, 2011; Barnett, Parmar and Ward, 2013)  also use this method to describe 
developing the New Medicines Service referrals. Barnett and McDowell (2012) and Barnett and 
Sanghani (2013) use exploration and understanding to describe a coaching approach to 
support medicines adherence. A continuous quality improvement approach has been used in 
similar work (Scullin et al., 2007)   which led to the development of an integrated medicines 
management service in Northern Ireland and shares the cyclical nature of action research. 
Action research is the most appropriate method for many of the author’s studies. The 
potential for bias is acknowledged in that the researcher is advocating the policy change rather 
than critically evaluating it. This risk of bias is minimised through the action of policy 
implementation which was supported by national and/or professional bodies and underpinned 
by similar work from other researchers in the field.  This method requires the researcher to 
obtain buy-in and involvement from other working practitioners. This can be challenging in a 
pressured work environment, particularly if the intervention is complex and/or the burden of 
work associated with the research is large. These challenges were addressed through engaging 
with participants to explore what was possible within their work environment and by 
encouraging participants (professional colleagues) to become invested in the study in which 
they were participating. In addition, collaborators were aware of the overall strategy and 
policy driving the change in order to understand application to their own practice, which 
supports engagement (University of Southern California, 2017).  
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2.2.2 Document analysis 
 More usually used in social research (Wharton, 2006) this method was chosen to support the 
retrieval and analysis of written data from national and professional policy, as well as key 
primary evidence to shape the direction of change. The author’s work included analysis of key 
NHS policies and the pharmacy implications arising from these policies, guidance from 
professional pharmacy bodies and guidance from other professions that use medicines to 
support better health for patients. Literature evaluation was limited to key national and 
professional policy and key studies. While the authenticity of the documents chosen were not 
in question, retrieval was undertaken using searches of Department of Health, professional 
body and organisation websites as well as contacting the organisations directly where 
required. Formal analysis of content within policy documents was not required as the policies 
included were underpinned by literature review and evidence from practice. The author 
undertook interpretation of the policy to provide recommendations for practice in the author’s 
field. Analysis of the evidence on which these recommendations were based was undertaken 
through review of references and sources for the document and analysis of these papers 
where appropriate. While the narrow nature of the search and analysis could potentially limit 
the learning, attempts at literature searching using standard Boolean searches of Pubmed and 
Embase with keywords such as person-centred care, pharmacy practice, older people, 
polypharmacy, medicines adherence and deprescribing and synonyms were too broad even 
when combined. In addition, these searches did not identify documents which influenced 
pharmacy practice in the direction of person-centred care.  The overall methodology relied on 
the quality of the key documents included, having been underpinned by appropriate literature 
review, and these documents are explored in the chapters ahead. 
2.2.3 Dialogue 
The author used the dialogic method, working with other practitioners in the field, to generate 
ideas. The dialogue leads to practitioners co-constructing a shared vision of a way forward and 
incorporating the author’s interests (Mathison, 2005). This method is linked to the 
collaborative method as part of action research (Paulus, Woodside and Zeigler, 2008). With an 
open exchange of ideas between experts, and active practitioners, dialogue was used to 
construct an understanding about the research subject and develop understanding within the 
participants themselves. Dialogue as a method was critical to the author’s own development 
through engagement with other people with whom the subject was discussed. This is the 
relational aspect of dialogue which then transforms the research into a learning experience 
and effects positive change. The challenge is for the researcher to have insight into both the 
positive and negative outcomes from this learning and implement change which may be 
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against the researcher’s prior beliefs (Given, 2008 pp. 212-213). This was demonstrated when 
the first publication on referral to the New Medicines Service resulted in poor referral rates 
and dialogue with colleagues working in the area promoted new thinking and a change in 
practice with better outcomes (Barnett, Parmar and Ward, 2013). Examples of use of dialogic 
methods leading to new insights include Barnett and White (2015), Barnett and Blagburn  
(2014) and Jubraj et al.,  (2016), to which the author contributed 20% of the work, Bhandal, 
Barnett and Clarkson (2016) to which the author contributed 30% of the work and Barnett and 
Parmar (2016). 
2.2.4 Collaborative research  
This method was central to the development of the work as dialogue with practitioners, some 
of whom were experts, led to collaboration in areas of shared interest and inquiry for mutual 
benefit, which is a feature of this method (Pushor, 2012). The author undertook collaborative 
research through identifying pharmacy practice leaders with an interest in the various aspects 
of person-centred practice. Centred on engagement of stakeholders, including practitioners, 
professional bodies, policymakers and patients, alongside each other, the work developed to 
identify questions and deliver answers in areas of mutual interest for patient benefit. This 
method requires the development of relationships to foster collaboration and aligned well 
with the author’s strengths as a researcher. The collaboration required equity between all 
partners so that working together achieved agreed goals.  
The challenge of collaborative research is not insignificant and requires investment in 
relationships to develop trust and rapport between all collaborators. This takes time and often 
requires some face to face contact, which can be difficult when researchers are physically 
distant. It requires awareness of individual’s agendas and of areas for potential conflict which 
must be resolved. This challenge was managed through the author using networking 
opportunities to develop relationships. The author also built up a reputation for equity in 
collaborative working in order to minimise potential issues around leadership, coordination, 
sharing workload and any other potential areas of conflict which can occur in this type of 
research (Given, 2008 pp. 93). Examples of collaborative research publications by the author, 
working with pharmacy colleagues on the subject of older people, includes Barnett and Taylor 
( 2004), Barnett and Taylor, (2006) Rutter and Barnett (2007), to which the author contributed 
50%.  Collaboration with colleagues from other disciplines also led to publications. This 
included collaboration with a psychologist and coach colleague describing a coaching approach 
to medicines adherence  (Barnett and McDowell, 2013) and collaboration with a pharmacist 
colleague who also practiced as a cognitive behavioural therapist (Barnett and White 2014). 
Other examples include Barnett, Oboh and Smith (2016), Bhandal, Barnett and Clarkson (2016) 
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and Barnett and Parmar (2016), the latter two publications involving collaborations with 
speech and language therapy colleagues. 
2.2.5 Praxis  
While not a core method, elements of praxis are key to the philosophy underpinning many of 
the studies included in this thesis. There was no prior knowledge of the “correct” way to 
develop person-centred care in pharmacy practice or the desired outcome. In addition, the 
meaning of person-centred care in specific circumstances was evolving and changing, as is 
common with learning from continuing research (Smith, 2011). Given that the author’s work 
extended over 20 years, it could be considered as an ongoing process in which establishment 
of key relationships between practitioners, for mutual benefit (Tierney and Sallee, 2012) was 
central to the success of the work. The “commitment to human well being” (Smith, 2011), 
underpinned much of the author’s work in relation to patient well-being.  In the context of this 
thesis, praxis did not refer to relationships where oppression occurred or where there was 
imposition of will on others, for example, where clinicians wield their status and power to 
influence patients’ health related decisions. 
2.2.6 Quantitative studies 
Quantitative methods were employed for pilot and small scale studies to explore potential 
ways of implementing change in practice. Prospective cohort studies were used to explore 
local practice in relation to national concepts. For example, Sood, Amin and Barnett (2005) 
describe implementation of services supporting the National Service Framework (NSF) for 
Older People (Department of Health, 2001), to which the author contributed 40%. Fertleman, 
Barnett and Patel (2005) identify benefits of pharmacists on admission ward rounds, to which 
the author contributed 40%, and Barnett, Vilasuso, Pettit and Hathi, (2014) describe issues 
around transfer of care, highlighted as of concern by the RPS. The author was invited and 
contributed to two publications for the pharmacy professional body (Royal Pharmaceutical 
Society, 2012 Royal Pharmaceutical Society 2013), as well as video recorded content (Royal 
Pharmaceutical Society, 2012). The author has contributed to several papers  (Barnett et al., 
2016b; Barnett, Kalsi and Patel, 2017; Barnett et al.,  2017) as well as Lang, Gulhane, Khoda 
and Barnett. (2017) to which the author contributed 20%. These publications describe services 
developed from the themes of the NSF for older people (Department of Health 2001). The 
work contributes to the aim of the recent review of hospital pharmacy services by Lord Carter 
of Coles (Department of Health, 2016) in providing more patient-focussed care.  
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While useful for identifying rare occurrences, challenges with cohort studies include the need 
to follow up large numbers over time. If the data gathered is retrospective, data may be 
absent and/or of poor quality (Boston University, 2017). Learning from the pilots included that 
these data did not include matched cohorts and this would be required if the pilots were to be 
developed into future studies. Undertaking pilots and small scale studies was challenging in a 
time-pressured hospital pharmacy environment and learning included the need to develop 
collaboration with academic colleagues for research support in advance of undertaking further 
work. Given that the overarching strategy was qualitative, the author’s publications did not 
employ quantitative methods to demonstrate causal relationships or support data collection in 
an experimental design, explore relationships between variables to test theories or include 
interviews, case studies or surveys. Pilots were used to explore feasibility of ideas and small-
scale quantitative studies were conducted to collect data required for the author’s local 
organisation and to support justification of local services. 
2.2.7 Combining the methods  
Methods as described above were combined in different ways to contribute to the overall 
research output. Some of the collaborative work was undertaken in a sequential way, that is, it 
was developed along a specific theme and timeline, where one piece of work led to another on 
the same theme sequentially. For example, the workstream around consultant pharmacists, 
developing the author’s leadership and research skills, included a variety of publications 
(Barnett, 2008; Barnett, Mason and Stephens 2009; Mason, Stephens and Barnett;, 2010). 
Other work involved action research using PSDA cycles, dialogue and collaboration and 
developed iteratively as a cycle or “spiral”. An example of this is the development of the 
Integrated Medicines Management Service (Athwal, Rosenbloom and Barnett, 2011) with both 
oral presentation (Barnett et al. 2016a,) and abstract following the initial publication (Barnett, 
et al., 2016b) and a further pilot (Barnett et al., 2017). Other work combined dialogue, 
collaboration, PDSA cycles and quantitative pilots where some work was sequential, such as 
development of the patient centred polypharmacy process (Barnett, Oboh and Smith, 2016).  
The author’s work on polypharmacy developed into related work on deprescribing, including 
publication of a themed journal issue, of which the author was joint editor, as well as posters 
and presentations. Examples on the theme of polypharmacy include papers such as a review of 
challenges in polypharmacy, (Barnett and Oboh, 2014) a description of a new model patient-
centred polypharmacy consultation model in the European Journal of Hospital Pharmacy 
(Barnett, Oboh and Smith, 2016), presentations including at the British Geriatric Society Spring 
Conference (Oboh and Barnett, 2016)  to which the author contributed 50%. Other 
publications include contributions to learning resources the CPPE polypharmacy learning 
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resource (Centre for Pharmacy Postgraduate Education, 2016a) and in the CPPE media wall 
videos (Centre for Pharmacy Postgraduate Education, 2016b). The author presented a keynote 
lecture on polypharmacy for the Royal College of General Practitioners and RPS Polypharmacy 
conference (Barnett, 2016)   and at the recent Prescribing Research in Medicines Management 
conference (Barnett, 2017a). 
2.3 Publication strategy  
The publication strategy chosen was designed to maximise exposure of the author’s work to 
the pharmacy profession, principally through publication in pharmacy professional journals 
e.g. Pharmaceutical Journal, Clinical Pharmacist, European Journal of Hospital Pharmacy. More 
recently online-only publications have been included in the publication strategy, such as 
Journal of Medicines Optimisation (JoMO) and Journal of Pharmacy Management (JoPM). The 
author’s publications in the various journals listed will be described in later chapters. Many 
publications were submitted and accepted by peer-reviewed pharmacy and allied health 
profession journals. These were chosen in preference to academic journals with higher impact 
factors to recognise the practice-based nature of the work and align with the aim of reaching a 
practice-based readership. Publications were also accepted by other non-peer reviewed 
pharmacy and other health professional journals to maximise exposure, for example the 
Health Service Journal. Contributions were made to books through writing chapters, (Barnett 
and Goldstein, 2016; Barnett and Tomlin, 2011; Cairns and Barnett, 2009)  to which the author 
contributed 50%, a chapter in the Clinical Pharmacy Pocket Companion (Ed. Gray et al., 2015)  
and a chapter in the Oxford Handbook of Clinical Pharmacy (Barnett, 2017) . The author’s work 
was disseminated through working with national organisations (CPPE, 2016), and National 
Institute for Health and Care Excellence (NICE) (2016).  As an RPS “ambassador” the author 
was involved in media work for the British Broadcasting Corporation (BBC) (2012), 
Independent Television (ITV) (Barnett, 2012a) to promote the development of person-centred 
care in pharmacy practice.  The author has also supported promotion of a person-centred 
approach, in collaboration with CPPE, through radio broadcasts for an Age UK radio channel, 
both on the subject of polypharmacy and on supporting people to get the most from their 
medicines consultations (Age UK and The Wireless Radio, 2016a;  Age UK and The Wireless 
Radio, 2016b).  
The author’s role in the Medicines Use and Safety (MUS) Division of the National Specialist 
Pharmacy Service has facilitated contributions to be made freely available through the website 
www.sps.nhs.uk, which provides open access. Webinars to educate and publicise new 
developments have been a recent addition to the MUS publicity strategy in which the author’s 
work has featured. This publication strategy continues to develop and links with potential 
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future work, increasing public awareness of the benefits of person-centred care in pharmacy 
practice. 
2.4 Summary of methodology 
 This chapter has described a mixed method approach, which mainly features action research, 
to demonstrate the author’s contribution in developing person-centred care in pharmacy 
practice. The methods were chosen allowed flexibility in developing services according to local 
need and to meet national strategic requirements, accommodating the changing landscape of 
pharmacy practice. The combination of action research (including collaborative and dialogic 
methods) with document analysis provided a platform to utilise existing guidance and policy to 
shape practice in an innovative and iterative way. The publication strategy illustrates the 
author’s motivation to disseminate the work among pharmacy and other related communities 
of health-care practitioners. This strategy was developed to encourage reflection, dialogue and 
experimentation with new practice towards a more person-centred approach to medicines–
related patient care. 
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Chapter 3: Development of person-centred care in 
pharmacy practice 
3.1 Older People 
Older people form a considerable proportion of health-care users and as life expectancy 
increases, health-care resources will become increasingly focussed on the older population 
(World Health Organisation, 2011). In 1951 male life expectancy was 66.4 years and female life 
expectancy was 71.5 years in England and Wales and over the 50 year period to 2001 this has 
risen to 76 years and 80.6 years respectively (Office for National Statistics, 2015).  This 
contrasts to a rise in the UK population from 50.3m to 59.1m (Jeffries, 2005) over the same 
time period. Importantly, there has been a steady increase in number of people aged 65 years 
in a 30 year period from  7.4 million in 1971 to 9.4 million in 2001 and the projected rate of 
growth in 2011 was from 10.5 million to 15.8 million in 2031.  In addition, it was predicted that 
the number of people over the age of 80 will increase by nearly half between 1995 by 2025 
(Department of Health, 2001). Finally, data from 2001 showed that there were 637 per 
100,000 over 90 (Office for National Statistics, 2014) and this had risen in 2015 to 867 per 
100,000 over 90 in England (Office for National Statistics, 2016). 
It was in 2001 that the National Service Framework for Older People highlighted the issue of 
the aging population in relation to health provision and medicines and stated that one fifth of 
the population was over 60 in England (Department of Health, 2001). The health challenges of 
increasing older age have been internationally recognised (World Health Organisation, 2011), 
with older people having significantly more health and social care challenges than their 
younger counterparts. These include the need to manage co-morbidities in older age as well as 
the requirements to manage an increased incidence of dementia and frailty (Oliver, Foot and 
Humphries. 2014). With an aging population comes the need to address the problems 
associated with increased use of medicines in older people, identified in the National Service 
Framework for Older People (Department of Health, 2001). Medicines issues include, for 
example, increased risk of adverse effects from medicines causing morbidity. More recent 
publications highlight the challenges of inappropriate polypharmacy (Duerden, Avery and 
Payne, 2013; Jones, 2013) where the risk of adverse effects of medicines and drug interactions 
was shown to increase with increasing number of prescribed medicines (Maher Jr, Hanlon and 
Hajjar, 2014; Guthrie, et al., 2015).  
 
 
37 
 
3.1.1 Medicines and older people 
According to section 1.2.2.2 of the NHS Constitution, and in line with national and 
international policy, the first of the NHS values is that patient-centred care must be at the 
heart of all NHS health-care provision (Department of Health, 2015). With pharmaceutical care 
being part of NHS provision, this requirement includes and is supported by the profession of 
pharmacy (Centre for Pharmacy Postgraduate Education, 2014; Picton, Dayan and Smith, 2014; 
General Pharmaceutical Council, 2015).  A review of NHS and pharmacy guidance from 1997 
onwards revealed three seminal documents (Royal College of Physicians of London, 1997;  
Department of Health, 2000;   Department of Health, 2001) which heralded a fundamental 
change in medicines-related care for older people.  The first edition of a report on Medication 
for Older People was published in 1984 (Black, Denham, Acheson et al., 1984) for the Royal 
College of Physicians (RCP) of London and this was the first national document to highlight the 
risks of inappropriate prescribing in older people. The report, updated in the second edition 
published in 1997 (Royal College of Physicians of London, 1997), recommended consideration 
of risk/benefits before prescribing and highlights the benefit of assessment being conducted 
without reference to age and on an individual basis. The report also reminded prescribers for 
the need for regular medication review. Looking back at the 1997 report it appears to have 
been ahead of its time, as many of the recommendations are included in later medication 
review documents (Shaw, Seal and Pilling, 2002; Clyne, Blenkinsopp and Seal 2008;NHS 
Cumbria Medicines Management Team, 2013) . The theme of medication review was central 
to many later documents relating to polypharmacy (Duerden, Avery and Payne, 2013; All 
Wales Medicines Strategy Group, 2014;  The Scottish Government and NHS Scotland , 2015;), 
as well as being included in the recent NICE multimorbidity guidance, (2016) , to which the 
author contributed as a member of the guideline development group.  
The RCP 1997 document provides robust guidance on the way forward for medicines-related 
care of older people and is underpinned by a literature search for key papers. While this 
document contains some unpublished observations (Duggan, Eccles and Ford, 1996; Tefft and 
Denham, 1995), it includes a variety of sources including commentaries (Adams et al., 1987) 
and reference to other specialist body publications (Royal College of Physicians, British 
Geriatric Society 1992) to substantiate the recommendations. 
The work of the author of this thesis began in response to continuing national and 
international identification of issues surrounding medicines-related care of older people (Royal 
College of Physicians of London, 1997, Canadian Society of Hospital Pharmacists, 2001, 
Department of Health, 2001).  
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Efforts to improve medicines-related care for older people include the introduction of 
medication review, which has developed over the past two decades in the UK (Zermansky, et 
al., 2001; Clyne, Blenkinsopp  and Seal, 2008; National Institute for Health and Care Excellence, 
2009;National Institute of Health and Care Excellence, 2015). However, this has also had its 
challenges (Holland, et al., 2005).  It is interesting to note that many of the clinical challenges 
highlighted in the NSF for Older People continue to exist, including the medicines-related 
management of long-term conditions, commonly occurring in older people (Royal 
Pharmaceutical Society, 2016). The recent RPS “now or never” report (Smith, Picton and 
Dayan, 2013) highlighted that there is a need for more and better management of long term 
conditions (LTC) and frailty. “Now or never” described how this can be delivered through 
improved coordination and increased efficiency, considering the delivery of new models of 
care. The long-term conditions theme has been developed further in the recent RPS report 
(Royal Pharmaceutical Society, 2016) and the drive to reduce inappropriate polypharmacy, 
particularly for the older population (All Wales Medicines Strategy Group, 2014), has gained 
momentum (The Scottish Government and NHS Scotland , 2015;Duerden, Avery and Payne, 
2013).  
3.1.2 Pharmacy practice and older people 
Pharmacy practice in a UK hospital setting in the 1990s focussed on good pharmaceutical care 
(United Kingdom Clinical Pharmacy Association, 1996). This grew from the seminal work of 
John Baker at Westminster Hospital (Baker, 1967) who observed the large number of 
medication errors due to a number of factors, including poor documentation of medicines 
orders brought to the pharmacy dispensary by nursing staff. This led to the establishment of 
ward-based pharmacy services in many hospitals, from the previously dispensary –only based 
service. It soon became apparent that patient-facing clinical pharmacy service was both 
possible and beneficial in ensuring provision of safe, effective use of medicines. The UK Clinical 
Pharmacy Association (UKCPA), formed in 1981, supported networking and education of 
clinical pharmacy professionals in order to share best practice.  Specialist groups developed 
within UKCPA, including a care of the elderly group, of which the author is a member. 
The author, as a pharmacist working with older people for more than 20 years based in a 
hospital setting, was initially introduced to the concept of multidisciplinary, holistic, patient-
centred care by a leading geriatrician, Dr Michael Denham. As chairman of the Royal College of 
Physicians report on Medicines and Older people (1997) and a past president of the British 
Geriatrics Society, Dr Denham was champion of multidisciplinary patient-centred care of older 
people. Collaborating with Dr Denham and a pharmacy researcher, Dr Sally-Anne Francis, then 
at the School of Pharmacy, University of London, the author contributed to two papers 
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exploring the pharmaceutical care of older people (Denham and Barnett, 1998), to which the 
author contributed 40%, and Barnett, Denham and Francis (2000). The first of these papers 
focussed on clinical aspects of risk and medicines for older people, such as the need for 
cautious prescribing and monitoring of high risk medicines, identifying adverse drug reactions 
and drug interactions, in line with the common practice at the time (Royal College of 
Physicians of London, 1997). The second article, about the lack of exploration by clinicians of 
over-the-counter medicine use (Barnett, Denham and Francis 2000) considers the dominance 
of a clinician perspective in consultations to explain the assumption that patients only take 
what is prescribed. The latter publication followed the author’s completion of a Master’s 
degree in Pharmacy practice dissertation which related to this area of practice, considering the 
lack of information gleaned by clinicians about over-the-counter (OTC) medicines use 
highlights potential risks, which are echoed by other authors (Honig and Gillespie, 1995). While 
the costs of OTC medicines were later identified as a risk to reducing access to medicines 
(Anonymous, 2004a), others suggested that there was benefit of reclassifying prescription-only 
to over the counter status (Anonymous, 2004b). The author’s publication (Barnett, Denham 
and Francis 2000) summarised the potential hazards of OTC medicines, such as patients being 
prescribed medicines that they also purchase OTC and masking or delaying diagnosis of serious 
conditions being treated with OTC medicines. The publication encouraged prescribers to ask 
patients about their OTC medicines’ use. 
Over the next five years, the author developed the pharmacy service for older people, 
describing the role of the pharmacist in the author’s organisation’s local publication 
(Anonymous, 2005). Pharmaceutical care for older people was being recognised as an 
increasingly important speciality (Canadian Society of Hospital Pharmacists, 2001)  and the 
participation of pharmacists in consultant Care of the Elderly ward rounds began to be 
described in the literature  (Burns and Still, 2003). Working with medical and nursing 
colleagues, the author continued to observe person-centred care as practiced by other health 
professions. In addition, the author worked to develop understanding of the role of the 
pharmacist, in relation to patients and as part of the multidisciplinary team (Carne, Barnett 
and Denham 2002). Through collaborative care delivered with community matrons and 
General Practitioners (GPs), the author worked to identify and manage medicines’ risk for 
patients at risk of preventable hospital admission. The author also described the expanding 
role of pharmacists in the care of older people in general practice, intermediate care and acute 
admission settings (Barnett et al., 2003; Barnett and Taylor, 2004; Sood, Amin and Barnett 
2005; Fertleman, Barnett and Patel 2005).   
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3.1.3 Medicines, older people and pharmacy practice 
Alongside the increasing participation of pharmacists in care of older people, the medicines-
related content of the National Service Framework for Older People (Department of Health, 
2001) introduced the concept of person-centred communication. This led the author to 
observe patient-clinician communication within the multidisciplinary setting of care for older 
people. This is reflected in another paper on OTC medicines use (Francis, Barnett and Denham 
2005), to which the author contributed 33%, where the author and colleagues identified that 
two-way communication is needed to encourage safe OTC use in the context of prescribed 
medicines and that this did not always occur. This paper was the start of the author’s 
consideration of the idea that medicines use requires a mutual responsibility for 
communication between patients and health professionals that is not always achieved in 
practice. 
3.1.3.1 Medication review 
Medication review is included here as an example of a process which benefits from a person-
centred approach. The importance of medication review, as part of clinical care for older 
people, was highlighted both by the Royal College of Physicians (1997) and in the National 
Service Framework for Older People (Department of Health, 2001). Hailed as a successful 
pharmacy intervention, following publication of a randomised controlled trial (Zermansky et 
al., 2001); medication review was suggested to be both a clinically beneficial and cost-effective 
method of optimising prescribed medicines. The following section will outline the author’s 
contribution to the medication review debate in relation to older people. 
 In 2005 a paper, published in the British Medical Journal (Holland et al., 2005), raised concerns 
in the pharmacy community. The paper suggested that medication review was, at best, not 
effective and, at worst, harmful to patients. This contrasted with previous published literature 
on medication review, which suggested benefit in terms of identifying medicines related 
problems in GP practices (Zermansky et al., 2001) and nursing homes (Furniss et al., 2000)  . 
Working with colleagues, the author initiated discussion of the findings of the Holland (2005) 
paper and published three related “rapid responses” (Bowyer and Barnett, 2005), to which the 
author contributed 50%, (Barnett and Smith, 2007; Barnett, Taylor and Bowyer, 2007). 
Discussion with colleagues concluded that sending pharmacists without robust, transparent 
medication-review training into the homes of patients who did not know them, to undertake 
medication reviews unconnected with all other health-care interventions and systems, was 
central to the failure of this medication review initiative. This highlighted the importance of 
communication between clinicians and patients, the absence of which can derail clinical intent. 
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When the National Prescribing Centre (NPC) produced guidance on medication review (Clyne, 
Blenkinsopp and Seal 2008), the author co-wrote an opinion piece and a review (Barnett and 
Oboh, 2009a; Barnett and Oboh, 2009b) that highlighted a gap in the NPC document. The NPC 
document did not emphasise that effective communication between the practitioner and 
patient and between carers and health and social care professionals was essential for effective 
medication review. In addition, the author wrote an article entitled “Stuck in the middle” 
about the need for pharmacists to engage patients being critical to success of health-care 
interventions (Barnett, 2011a).  
A recent systematic review and meta-analysis of effectiveness of medication review (Huiskes 
et al., 2017) concluded that one-off medication reviews in short term situations, while having 
an effect on medicines-related outcomes, including reducing medicines-related problems, 
have little effect on clinical outcomes and none on quality of life. No conclusion could be 
drawn for cost-effectiveness. Other work (Szymanski, 2016) found that a single comprehensive 
medication review was cost-effective in a hospital setting in the UK.  The meta-analysis 
recommends that one-off medication reviews are no longer carried out.  However the review 
was a meta-analysis of 15 heterogeneous studies in different countries and varying health 
settings without standardisation of medication review methods, for which there is no accepted 
practice national standard used in the literature, and this reduces the impact of the conclusion 
of the meta-analysis. 
3.1.3.2 Medication compliance and self-medication 
At the same time, work around compliance with medicines was beginning to develop in the 
pharmacy community in the UK (Horne et al., 2005).  The author was involved in discussions 
with pharmacy colleagues about how to approach the challenge of medicines compliance  
(Barnett and Taylor, 2006) and continued to learn about person-centred consultations through 
multidisciplinary working, learning from others through visits to patients and work with 
community matrons (Jenner and Barnett, 2006) , to which the author contributed 50%, and  
Barnett (2006). The author also commented on the effectiveness of community-based 
interventions (Barnett et al., 2007). Continuing the work of the National Service Framework 
(2001) the author sought to address the medicines management “milestone” of self-
administration of medicines in the author’s local trust, to support person-centred care for 
older people. Working with a medical colleague on introduction of hospital self-medication 
(Vilasuso and Barnett, 2007), to which the author contributed 50%; the author developed an 
understanding of the importance of patient autonomy in pharmaceutical care. Local work 
revealed that both the acuity of illness of patients on the care of older people wards and their 
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lack of desire to self-administer medication made self-administration of medication in an acute 
setting both ill-advised and impractical.  
3.2 Clinical leadership 
Clinical leadership is a skill required to implement change in practice.  Having published in the 
field of pharmacy and older people, the author responded to two opportunities in the 
pharmacy profession at the start of the millennium to develop leadership skills. The first was 
the establishment of the pharmacist prescriber role following a review for the Secretary of 
State for Health by Dr June Crown (1999). This review recommended that “The legal authority 
in the United Kingdom to prescribe, including authorising NHS expenditure, should be 
extended beyond currently authorised prescribers” to include others, such as pharmacists. This 
review introduced the concept of independent and dependent, later known as supplementary, 
prescribing and required that new “non-medical” prescribers, i.e. not medical or dental 
prescriber, could undertake a prescribing role following specific training. The author enrolled 
in the first cohort of pharmacists to train as supplementary prescribers and later converted the 
qualification, achieving independent prescriber status and joining the staff at King’s College 
London to train other “non-medical” prescribers. The prescriber role supported the author in 
providing leadership to develop the profession following the Francis Inquiry (2013). 
The second opportunity for development of leadership in pharmacy practice was provided by 
the publication of guidance on Consultant Pharmacists, issued by the Department of Health 
(2005). The new Consultant Pharmacist role was established to provide patient access to 
leading pharmacy practitioners with skills in a specific expert area of practice, who also 
engaged in research and service development, education, mentoring, management and 
leadership. The author’s role was developed to fulfil the requirements of the Consultant 
Pharmacist framework (Department of Health, 2005) and a local Consultant Pharmacist post in 
the Care of Older People was created and approved, to which the author was appointed in 
January 2007. The author established a consultant pharmacist group in East and South East 
England (the author’s geographical region of work) and this developed into a national group, of 
which the author was chair from 2008-2012. The group was incorporated into the RPS in 2012. 
The author is currently joint chair, with Professor Nicola Stoner, of the national group of over 
70 Consultant Pharmacists and in 2015 the author led a national showcase event to highlight 
the achievements of the post-holders of consultant roles. While there is evidence from 
publications of the individual practitioners to demonstrate the impact of the roles, examples of 
which are highlighted in the Consultant Pharmacist Toolkit on the NHS Specialist pharmacy 
service website  (Barnett & Stoner, 2017a), there is no published evidence for the roles overall. 
The author is currently leading the development of the consultant pharmacist strategy to 
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support development of roles in England. This was presented at the 2017 Clinical Pharmacy 
Congress (Barnett & Stoner, 2017b). In addition, the author is leading collaboration between 
consultant pharmacists working with older people across all four UK countries, establishing 
this group as a subgroup of the consultant pharmacist group. 
3.2.1 Pharmacist prescribing 
Pharmacist prescribing presented an opportunity for the profession to expand its contribution 
to clinical care of patients, through better utilisation of pharmacists’ skills in both primary and 
secondary care services to promote timely provision of clinically appropriate, safe 
prescriptions. The author demonstrated leadership in pharmacist prescribing through 
publication in the professional journal section “Agenda for 2003” (Barnett, 2003), describing 
the evolution of pharmacy practice from a focus on the prescription to one which included the 
patient perspective. The author also worked with the RPS to develop pharmacists as 
champions of prescribing to improve pharmaceutical care of older people. The author led the 
establishment of a supplementary prescribing service in a Harrow Primary Care Trust nursing 
home with 30 beds. As project lead for the London Pharmacy Supplementary Prescribing team  
the author described, in a later publication   (Barnett and Nicholls, 2005), the benefit of the 
role to patient care, providing timely, safe access to prescription medicines for patients. In 
addition, this publication included identification of the importance of a relationship of 
professional trust and respect between pharmacist prescriber and medical prescriber to the 
success of this role. The pharmacist prescribing role was promoted to a multidisciplinary 
prescribing audience through publication of a description of the author’s role with case 
examples   (Barnett, 2007). As a newly appointed Consultant Pharmacist in 2007, the author 
challenged the pharmacy profession to consider how pharmacist prescribing could contribute 
to hospital ward-based patient care (Barnett, 2008). In a reflection on the prescribing role as 
an independent prescriber (Barnett, 2012b), the author recognised how pharmacist 
prescribing, with appropriate prescriber competency and in the right patient situation, 
provided an opportunity to deliver care focussed on patient-need. This was described in a 
publication which outlined a case example where a simple modification of a medicines 
regimen for paracetamol provided improvement to a patient’s quality of life. Critics of 
pharmacist prescribing voiced concerns about the lack of diagnostic skill of pharmacists 
causing risk to patients (Stewart et al., 2009); however these assertions were not evidence 
based. Subsequent data on pharmacist prescribing revealed a much lower prescribing error 
rate for pharmacists than for medical prescribers. One study found an error rate of 0.3% for 
pharmacist prescribers  (Baqir et al., 2014a) compared to a study of foundation year doctors 
which suggested a mean error rate of 8.9 errors per 100 medication orders (Dornan et al., 
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2011) .  Another publication reviewing error rates, including medicines omissions, in hospital 
found a rate of 43.8% which was not linked to grade of doctor (Seden et al., 2013) .  The recent 
review of hospital pharmacy service by Lord Carter of Coles (Department of Health, 2016) calls 
for more pharmacist prescribers to contribute to medicines optimisation through direct clinical 
care (Winter and Adcock, 2016).  
3.2.2 Consultant Pharmacist  
Once appointed to the role of Consultant Pharmacist, in January 2007, the author published a 
“comment” article (Barnett, 2008) which identified the role as filling a gap in clinical career 
progression for NHS employed pharmacists. The author also highlighted the additional 
responsibilities of the new designation, including professional leadership. However, not all NHS 
pharmacy service leads viewed the role as a positive addition to NHS pharmacy services, 
preferring to maintain senior roles in either expert practice or management and leadership. 
This, together with financial constraints in the NHS, contributed to the patchy uptake of the 
role by NHS organisations.  
Evidence of the author’s leadership to promote the role as part of the pharmacy profession 
continued with the publication by Barnett, Mason and Stephens (2009). This collaboration, 
with the national directors for community and primary care and hospital care pharmacy 
respectively, identified the need for a career structure in pharmacy. This article was followed 
in 2010 by a call to the profession to develop these roles in support of improving quality of 
patient care (Mason, Stephens and Barnett 2010) to which the author contributed 33%. The 
consultant role was described in a book chapter (Barnett and Tomlin 2010), which emphasised 
the leadership role of consultants alongside clinical expertise, research activity and support for 
education.  Uptake of the role continues to be variable as some lead pharmacists continue to 
focus on high-level clinical expertise alone. However, the author has continued to promote the 
consultant pharmacist agenda, highlighting research, education and leadership as integral 
aspects of senior clinical NHS pharmacy roles. In the author’s role as the joint chair of the RPS 
Consultant Pharmacist Group, a showcase event was organised in June 2015 to highlight the 
various areas of expertise to which the consultant pharmacist role had contributed. This was 
supported by the Chief Pharmacist for England, Dr Keith Ridge, who suggested that the 
number of Consultant Pharmacists should “increase ten-fold” across the country in the next 
ten years  (Robinson, 2015) from the approximately 50 roles at the time. A stakeholder event 
followed in January 2016, which led to the development of a consultant pharmacist strategy 
and was presented at the RPS conference in September 2016. The author and joint chair 
colleague are currently developing a resource for commissioners of consultant posts and for 
post-holders. The content from this site will form part of the RPS series of “Ultimate Guides” 
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and is informed by the author’s publications which discussed the potential methods for 
developing career progression for pharmacists (Barnett, Mason and Stephens., 2009). This 
resource is being developed with the RPS and will support lead pharmacists who wish to 
consider establishing consultant roles in the future. The content will be aligned with clinical 
need in specific geographical areas of England, working with all four UK nations to develop 
consultant role in all countries and across health economies.  
 3.3 Impact of work with older people and clinical leadership 
The impact of the author’s contribution to the specialist area of practice of older people is 
evident from the case-based work introduced by the author as part of the clinical diploma 
(1999-2001). This was followed by  developing and delivering a Masters level course module 
on care of older people (2001-2008), both at the School of Pharmacy, University of London. 
Working with colleagues, the author led the development of a curriculum for pharmacists 
working with older people, using national guidance and key publications to identify topics, to 
create content appropriate for practitioner development in that area. The resulting curriculum 
document was endorsed by the British Geriatrics Society and incorporated into the resources 
to support the RPS Faculty framework, setting the knowledge standard for pharmacists 
working in this area of practice. The RPS older people curriculum continues to be requested 
through the United Kingdom Clinical Pharmacy Association (UKCPA) by practitioners within and 
outside the UK (Taylor, 2017).  
The author was invited to be a member of the project team and contributed to the original 
edition in 2010 and the updated 2015 edition of CPPE’s distance learning programme on older 
people (Centre for Pharmacy Postgraduate Education, 2015). In addition, the author 
collaborated with multidisciplinary colleagues to highlight the role of pharmacy in relation to 
older people (Barnett et al., 2003; Barnett and Taylor, 2004). Development of leadership skills 
was then essential to allow the author to champion a more person-centred approach in 
pharmacy practice. The author’s advancement of both the pharmacist prescriber role (Barnett, 
2003), which resulted in establishing a new pharmacy service for patients in long-care, 
followed by publication and development of the national consultant pharmacist group, now 
leading national strategy (Royal Pharmaceutical Society, 2016a), illustrate the growth of the 
author’s skill set in leadership in preparation for the advancement of person-centred care in 
pharmacy practice. 
46 
 
3.4 Summary 
Clinical expertise, as a specialist working with older people, developed during the author’s 
practice working with this patient group. The author’s development was supported by a clinical 
mentor, Dr Michael Denham, who led nationally in the speciality. The clinical environment in 
which the author worked eschewed a multidisciplinary, person-centred approach to patient 
care and increased the author’s understanding of the patient perspective.  Contribution of the 
author’s clinical pharmacy expertise into the multidisciplinary team environment provided an 
essential foundation to the author’s experience, as described in section 3.1.2. This work helped 
the author to conceptualise how a person-centred approach to care could translate into 
pharmacy practice which, at the time, was being taught and practiced with an emphasis on the 
clinical aspects of patient care. Development of the author’s research skills was supported 
both by working with Dr Michael Denham, who was widely published, and through links with 
local Schools of Pharmacy. The development of the author’s leadership skills, through 
pharmacist prescribing and the consultant pharmacist role, enabled the local person-centred 
approach to pharmacy practice for older people to be disseminated in the wider pharmacy 
arena. 
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Chapter 4. Implementation of person-centred care in 
pharmacy practice 
The following chapter describes the establishment of a cross-sector multidisciplinary clinical 
service to reduce preventable medicines-related re-admission. This work was initiated 
following a local project (Barnett and Francis, 2002) to implement the NSF for older people 
(Department of Health, 2001). This project, undertaken in 2002, demonstrated that medicines-
related care could be cost –effective and improve care for patients. In this project, a service 
was provided to identify patients who required more support with medicines than the 
standard pharmacy service and provide them with additional pharmacy services. Some 
patients were identified as requiring support with understanding the rationale for prescribed 
medicines as well as safe, effective medicines use. The service was designed to improve 
efficacy and safety of medicines use as part of medicines optimisation and included ensuring 
those patients’ medicines list prior to admission were correct on admission and that 
communication of medicines changes to the next sector of care was undertaken on discharge.  
Comprehensive clinical medication review and  information from cross-sector communication 
resulted in identification and management of 213 medicines-related problems in 91 patients. 
As part of this project, the author undertook the activity of ensuring those patients’ medicines 
list prior to admission was aligned with the hospital list, later known as medicines 
reconciliation. Some years later medicines reconciliation was highlighted by NICE (National 
Institute for Health and Care Excellence, 2007) in patient safety guidance, which included 
national requirements and metrics for undertaking this activity.  
The Care of Older People pharmacy service led by the author was developed from initial 
provision of clinical pharmacy services. Prior to 2004, pharmacists visited wards for older 
people to provide medicines supply, with minimal time for provision of advice on safe, 
effective medicines use. The author was successful in obtaining funding from the local 
organisation, using the data from the 2001/2 project, to provide two dedicated ward-based 
pharmacists for the four wards for older people.  The care of older people service was 
informed by pharmacy services developing at the same time in Northern Ireland.  A study 
published by Scullin, et al. (2007) describes the Northern Ireland service which focussed on 
reducing preventable medicines-related re-admission through comprehensive pharmaceutical 
care throughout the patient’s hospital stay.  Soon after the publication of the Scullin et al 
paper (2007) IMMS was established at the author’s local organisation, Northwick Park 
Hospital, incorporating a clinical and communication-based approach to identifying patients at 
risk and reducing risk of preventable medicines-related re-admission. This included 
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establishment of an additional pharmacist role, focussing on reducing preventable medicines-
related admissions, managed by the author. 
In order to develop the communication aspect of IMMS, the author undertook training in a 
coaching approach to communication and sought to apply this approach to health-related 
consultations. This was an innovative approach at a time when the benefit of behavioural 
approaches to improve adherence to lifestyle and medicines was beginning to be explored   
(Olsen & Nesbitt, 2010 ). Subsequent health coaching training allowed the author to consider 
the use of this set of techniques to deliver a coaching approach in pharmacy practice, which 
led to delivery of health coaching training to over 60 pharmacy staff in the author’s 
organisation in 2016.  
Health coaching is designed to raise patients’ awareness of their health issues and increase the 
patient’s own responsibility for managing their health (Health Education England, 2015). 
Interpreted for use in medicines-related situations, this allows health-care professionals to 
help patients identify what they need to do to improve their own health through medicines. 
Health professionals can facilitate this with expert knowledge where required. The author 
identified this skill set as one which promotes person-centred care and this now is supported 
by national policy (Department of Health, 2014, National Health Executive, 2015). The author 
became an experienced health coach trainer and developed a coaching approach for pharmacy 
consultations (Barnett and McDowell, 2012), integrating this approach into IMMS and 
implementing person-centred care in pharmacy practice locally. 
This chapter describes how the author pioneered the national development of a coaching 
approach to pharmacy consultations, initially to support medicines adherence and latterly to 
promote the use of person-centred methods in consultations about polypharmacy and 
deprescribing. The author developed, with colleagues, a nationally recognised process for 
optimising polypharmacy consultations and led discussion in the literature about the 
importance of medicines-related person-centred consultations to meet the new legal 
requirements for informed consent around medicines taking.  
4.1 Integrated medicines management service (IMMS) to reduce 
preventable medicines-related re-admission 
The National Service Framework (NSF) for Older People (Department of Health, 2001) provided 
guidance to develop pharmacy services focussed on high-quality clinical care with good 
communication between health-care professionals.  The supplementary publication to the NSF 
for Older People, entitled “Medicines and Older People” (Department of Health, 2001a) , 
contained recommendations to improve the quality of clinical care and reduce medicines-
related risk for this population. The recommendations included increasing involvement of 
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older people and their carers in medicines-related treatment decisions in order to improve 
quality of life as well as addressing poor adherence to medicines. IMMS was developed as a 
local strategy to respond to the challenges highlighted in the NSF for Older People. 
4.1.1 Local development of IMMS 
In 2001 the author was successful in obtaining local funding from the local primary care 
organisation to undertake a six-month hospital-based pilot project addressing key 
recommendations from the NSF “medicines and older people” document (Department of 
Health 2001a) , including establishing medicines reconciliation, medication review, discharge 
planning, communication with General Practice and post-discharge follow-up for patients on 
wards for older people. The pilot, published by Barnett and Francis (2002)   described benefits 
to clinical, communication and cost-related aspects of care and led to the establishment of a 
pharmacy service for older people within the author’s base hospital in 2004. Benefits included 
identification of 120 medication history discrepancies in 55 admissions on one care of older 
people ward. 171 changes to patients’ medicines were initiated. A cost saving of £86.24 per 
patient per year across the whole health economy was identified. Introduction of patient-
centred pharmacy service to provide medication review was estimated to deliver a saving of 
£29,000 per year. 
Around the same time, similar work was being undertaken in other centres to reduce 
preventable medicines-related re-admission. In the USA evidence was emerging for reduction 
in adverse effects at 30 days post discharge when full medicines support in hospital and post 
discharge telephone calls were undertaken (Schnipper et al., 2006).  In the UK, a randomised 
controlled trial, published by Scullin et al., (2007), described a hospital based pharmacy service 
to patients identified at risk of preventable medicines-related problems at admission, 
providing pharmacy interventions during hospital admission and at discharge. Patients were 
randomly assigned to IMMS, providing comprehensive pharmaceutical care (371 patients), or 
usual care (391 patients). The results of the Scullin et al., (2007) study show a statistically 
significant reduction for the average length of in-patient stays overall by 2 days, from 9.8 days 
to 7.8 days (p=0.003). The number of re-admissions to hospital was shown to be significantly 
different between the two groups (p = 0.027; Fisher's exact test) with 40.8% of the IMMS 
group being readmitted within 12 months compared with 49.3% of the usual care population. 
The study suggests that for every 12 patients receiving the service, one hospital re-admission 
within 12 months of discharge can be prevented. This work was reproduced on 2 hospital sites 
and showed a reduction of average length of stay of 1.49 days (Scullin et al., 2012).  This type 
of service was replicated in other countries (Schnipper et al., 2006; Gillespie et al., 2009). 
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Through attending and presenting at conferences the author developed links with pharmacists 
implementing IMMS and continued learning from various publications. Contact with the 
authors of the Northern Ireland paper (Scullin et al., 2007) helped to develop IMMS at the 
author’s local organisation and address improving transfer of care, communication and clinical 
care to contribute to improving medicines-related health outcomes for older people.  
IMMS was established in 2008 with a full-time pharmacist dedicated to identification and 
management of patients to reduce risk of preventable medicines-related re-admission. The 
core service was developed, using a quality improvement approach:  in-service Plan Do Study 
Act techniques (NHS Institute for Innovation and Improvement, 2008) were used as part of 
action research. 
The service included: 
 Medicines reconciliation, that is, comparison of pre-admission medicines list with the 
list of prescribed medicines on admission to ensure prescribing of the correct 
medicines. 
 Medicine optimisation, including stopping or starting medicines, titrating medicines to 
clinically effective doses etc. 
 Medicines consultations with patient and/or carers, including discussion of newly 
prescribed, stopped and changed medicines. All members of the team received formal 
training in health coaching during 2014 to support medicines-related consultations. 
 Full documentation of medicines changes and monitoring required on the discharge 
notification sent to GPs and, where appropriate, to pharmacies. 
 Medicines-related discharge planning with patients, carers, health and social care 
teams in primary and secondary care including medicines compliance aid assessment 
where appropriate and medicines counselling. 
 Pre-discharge referral to primary care health and social care professionals, contact 
with carers and, where appropriate, referrals to community pharmacists for the New 
Medicines Service or discharge Medicines Use Review. 
 Post-discharge telephone follow-up with patient and / or carers to support medicines-
related care. 
A case management tool was developed to identify risks in the first 50 patients seen in the 
service (Barnett, Athwal and Rosenbloom, 2009a) with root cause analysis undertaken for the 
three most complex patients who had repeated admissions.  With no nationally accepted risk-
identification tool, factors influencing risks were identified from the literature. The information 
from the initial 50 patients contributed to the development of an evidence-based tool to 
identify patients at risk of preventable medicines-related hospital re-admission, known as the 
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“PREVENT©” tool. This was developed and established for use in the local service (Barnett, 
Athwal and Rosenbloom, 2011).  
Collaborating with another leading pharmacist working with older people, a joint paper was 
published to raise the profile of the need to identify older people with  medication-related 
risks  (Barnett and Oboh, 2008). Discussion of risk identification tools were later the topic of a 
publication with a national colleague (Barnett and Seal 2013) where key factors that increased 
risk of preventable medicines-related re-admission were identified, including medicines 
adherence and polypharmacy. Preliminary results of IMMS were published (Barnett, Athwal 
and Rosenbloom 2011) where IMMS at the author’s local organisation was based on the 
Northern Ireland model (Scullin et al., 2007), as this was the closest health-care system and 
hospital organisation to the author’s own. These results described reasons for referral to the 
service and number of preventable medicines-related re-admissions at 30 days for patients 
managed through IMMS, that is, in the high risk cohort.  The ongoing development of the 
service was published in a descriptive study (Barnett et al., 2016b) and a pilot parallel cohort 
study published in July 2017 (Barnett et al., 2017).  
The author collaborated with a national leader to write a review of the status of services to 
reduce preventable medicines-related hospital re-admission   (Barnett and Blagburn, 2016) 
identifying the ongoing challenges in understanding the causes of such re-admission. The 
publication highlighted four themes: a person-centred approach to education, shared decision 
making, medicines reconciliation on admission and discharge and post-discharge referral to 
community pharmacy. All these services were provided as part of IMMS. A parallel cohort pilot 
study was undertaken to explore the potential benefits to patients of the current service in 
comparison to the standard pharmacy service and an abstract of this work was published in  
Age and Ageing (Barnett et al., 2016a) and presented at the British Geriatric Society 
conference in Spring 2016. This study showed that IMMS produced a statistically significant 
reduction in preventable medicines-related hospital re-admission (PMRR) at 30 days post 
discharge. 119/744 (27%) of patients in the active cohort were readmitted within 30 days of 
discharge with 2 patients (0.3%) due to a preventable medicines-related re-admission (PMRR) 
while 17/92 (18.5%) patients in the control group were readmitted within 30 days of discharge 
of whom 4 had a PMMR (4.4%). The difference between control and IMMS patients 
readmitted due to PMRR was statistically significant (P<0.002, Fisher’s exact test). However 
these results were difficult to compare to Scullin et al., (2007) because the author’s 
organisation required data on reduction of preventable medicines-related re-admission within 
30 days and the Scullin work reported results at one year. The Scullin et al., (2007) paper 
reports unplanned re-admission rates with length of stay and length of time to re-admission 
over 12 months; however preventable medicines-related re-admissions are not separately 
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identified due to the challenges of identifying these patients.  As current admission coding at 
the author’s local organisation does not provide this information, the author used pharmacist 
clinical judgement, peer-reviewed by a consultant geriatrician, to identify preventable 
medicines-related re-admission. However it is acknowledged that this method is subjective 
and alternative methods have been the subject of discussion with Scullin et al and others 
working in the field.  Furthermore, Scullin et al., (2007) and the author’s study reported 
different measures of success:  Scullin et al., (2007) reported reduction in length of stay and 
number needed to “treat” whereas Barnett et al., (2016b) reported number and type of 
interventions made as well as an estimate of cost savings in hospital. 
While identifying potential for cost and clinical benefits of the service, the paper by Barnett et 
al., (2016b) included methodological flaws which precluded further work with these data. 
Despite guidance on statistical requirements including control group size, the control group 
being smaller than the active cohort together with lack of demographic and clinical 
condition/morbidity data for the control group meant that comparison of the two groups was 
not possible.   
In addition, while the PREVENT© tool was used to identify patients in Barnett et al. (2016b), the 
re-admissions were assessed according to whether they were medicines-related or not.  It 
would have been preferable to assess re-admissions using the PREVENT© criteria, as these 
criteria were used to identify patients on initial admission. Peer-review of reason for re-
admission was undertaken by a peer independent of the study and this could have been 
improved if more than one peer reviewer had been involved.  As mentioned earlier, the re-
admissions were also reviewed in relation to 30 days where the original study (Scullin et al., 
2006) reviewed re-admissions at one year. A larger study is required to detect the influence of 
reducing preventable medicines-related re-admission on the overall re-admission rate.  
The literature suggests that 5-20% of admissions are medicines-related (Williamson and 
Chopin, 1980; Pirmohamed et al., 2004), and an unknown number of preventable medicines-
related re-admission, making comparison with the author’s data difficult. All the 
aforementioned issues will be addressed in future data collection. Nevertheless, the 
experience invaluable in developing the author's understanding of undertaking research in 
practice and has provided important information for the future development of the service. 
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4.1.1.2 Health coaching and integration of a person-centred approach 
within IMMS 
Developments in person-centred care as part of IMMS began with a personal reflection 
(Barnett, 2011) following the author’s training in health coaching. While a systematic review of 
the health and wellness coaching literature (Wolever et al., 2013) defined health coaching as 
“a patient-centred process that is based upon behaviour change theory and is delivered by 
health professionals with diverse backgrounds”, this review concluded that there is no 
overarching definition of the interventions referred to as “health coaching” in the literature.  
Health coaching focuses on the patient’s identification of their health-related needs. It uses 
techniques from psychology and performance coaching to help the patient identify a health-
related goal and develop their own options for solving the issues they raise. It can be 
considered as an umbrella term for a number of behavioural change methods. Health coaching 
has been identified in the NHS 5 year forward view (Department of Health, 2014) as a method 
of supporting healthier behaviours and can be applied to medicines adherence (Wolever and 
Dreusicke, 2016). The author chose to use health coaching to develop person-centred care in 
pharmacy practice as it provided an “umbrella” of behaviour change techniques. The author 
was aware of other behavioural change techniques beginning to be used in pharmacy practice, 
such as motivational interviewing (Stanton and Lyon, 2015) and cognitive behavioural therapy 
(White, 2014). The author sought out other practitioners working with behaviour change, such 
as health psychologists Dr Angel Chater (then at UCL School of Pharmacy) and Dr Vivian 
Auyeung (King’s College London),  collaborating to develop the coaching approach and 
contribute to the wider person-centred care arena. One such collaboration resulted in co-
authoring of a paper on empathy in clinical consultations (Jubraj et al., 2016) to which the 
author contributed 20%.  
The use of health coaching in consultations supports patient empowerment and can 
contribute to increasing patient activation, promoting shared decision making and improving 
patient engagement with health-care to contribute to better health outcomes and quality of 
life. A potential opportunity arose in 2016 to collaborate with primary care and use the 
recently purchased local licences for use of the Patient Activation Measure (NHS England, 
2017). This is a validated tool to support clinicians in working with patients towards increased 
self-care. However organisational issues precluded the inclusion of the PAM tool as part of 
IMMS. 
The author used health coaching skills and techniques to develop a coaching approach to 
pharmacy consultations as part of IMMS delivered pharmacy health coaching training 
programmes within the author’s organisation from 2014 onwards. The first programme, co-
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delivered with The Performance Coach in 2014, was part of a health coaching programme 
accredited by the European Mentoring and Coaching Council, working with Portsmouth 
University. The coaching approach became integral to the development of IMMS, described by 
Barnett, Dave, and Athwal et al. in 2016 and health coaching training has now been 
commissioned for health-care professionals working in the North West London area. 
The benefit of a coaching approach to consultations was demonstrated through video 
recorded consultations in which the author demonstrated the techniques applied to pharmacy 
practice (Imperial College London, 2014). The author also pioneered the use of a person-
centred approach in the dispensary setting. This included using the coaching principles to 
develop a consultation structure suitable for very short (2-5minute) pharmacy consultations 
(Barnett and Flora, 2017) enabling use of a coaching approach to more patients within the 
author’s organisation. In order to provide learning opportunities about person-centred short 
consultations, video consultations were created with an educationalist colleague, Barry Jubraj, 
and CPPE, to support integration of a coaching approach into pharmacy practice in short 
consultations (Barnett and Jubraj, 2014a, Barnett and Jubraj, 2014b). 
4.1.1.3 Multidisciplinary teams in the context of integrated medicines 
management  
The integrated medicines management service adopted a multidisciplinary team approach 
from its inception, having developed from the discipline of working with older people, where 
this is embedded in clinical care. The IMMS pharmacist was encouraged to attend medical 
ward rounds in order to identify pharmaceutical issues from a person-centred, as well as a 
clinical, perspective and make recommendations at the point of clinical decision-making. This 
has been demonstrated to be of value in the published literature (Bednall, McRobbie and 
Russell, 2003; McFadzean et al., 2003) with regard to emergency admissions to hospital.  
The author undertook a retrospective audit of pharmacist interventions on the general medical 
acute admission unit and prospectively gathered data when the pharmacist attended post-
admission ward rounds (Fertleman, Barnett and Patel 2005). This study demonstrated the 
benefit of attending the medical ward round to patient care in terms of intervention rate and 
clinical risk reduction, as well as cost-effectiveness. This included the identification of 
discrepancies in medication admission history in 52/53 (98%) patients seen by the pharmacist 
on the post-admission ward round, compared to 26/50 (52%) when medication admission 
histories were undertaken in a standard ward pharmacy setting.  In addition, pharmacists on 
the post-admission ward round stopped 42 medicines in 19 patients compared to 5 medicines 
in 3 patients seen as part of the standard ward pharmacy service. This work was undertaken at 
a time when stopping a medicine, also known as deprescribing, was not routinely considered.   
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As approximately two-thirds of emergency admissions at that time were older people, this 
contributed to local evidence of need for pharmacist integration into multidisciplinary teams 
both within IMMS and in wider pharmacy services. These findings were supported with later 
work demonstrating pharmacist value in intermediate care (up to six weeks after hospital 
admission) (Amin, Dave and Barnett, 2011), to which the author contributed 33%. This audit 
showed that the rate of interventions in an intermediate care setting (up to six weeks 
rehabilitation care) was 2.2 per patient and was comparable to other published hospital-based 
intervention audits (1- 5.5 interventions per patient) reinforcing the need for clinical pharmacy 
services in this setting. The author developed and implemented pharmacy services as part of a 
prevention of hospital admission “Rapid Response” service (Barnett, Kalsi and Patel, 2017). 
This paper described the contribution of a pharmacist to prevention of medicines-related 
admissions. With an average number of 9 regular medications, the pharmacist identified that 
68 (30%) of the 229 patients reviewed had a medicines-related issue or error with potential for 
moderate or severe harm, as classified using the National Patient Safety Agency 2011 
definition of harm scale (National Patient Safety Agency, 2011). 
4.1.1.4 Medicines support for special populations 
The author contributed to person-centred patient support with practical aspects of medicines 
use through collaboration with multidisciplinary colleagues in areas not yet addressed by the 
pharmacy profession. This included production of a resource for improving medicines-related 
communication about anticoagulation with patients after stroke and practical guidance for 
medicines use in patients with swallowing difficulties.  
This work evolved from a learning event provided for pharmacists in 2014, where pharmacists 
involved in care of patients after stroke identified a gap in practice when consulting with 
patients about safe use of anticoagulation therapy. Working with speech and language therapy 
colleagues, the educational material on anticoagulation therapy currently provided for 
pharmacy consultations was recognised as not suitable for people with receptive and 
expressive aphasia. This condition, which manifests as difficulty with speech and 
understanding, commonly follows stroke and anticoagulant medication is often prescribed. 
The author organised a further learning event and invited speech and language therapists to 
work with pharmacists in optimising communication for people with aphasia. Collaborating 
with speech and language therapists and pharmacists, the author facilitated co-creation of a 
set of slides which explained anticoagulation therapy in a suitable format for patients with 
aphasia. This was a novel communication tool for pharmacists and was distributed through the 
author’s organisation’s open-access website (Barnett, 2016).  Working with a leading 
pharmacist and a senior speech therapist, the author published a description of the tool to 
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support consultations for people with aphasia following stroke (Bhandal, Barnett and Clarkson 
2016).  
Using similar methods which included a learning event and collaboration with speech and 
language therapists, the author worked with a pharmacist expert on managing medicines for 
patients with swallowing difficulties after stroke and co-produced a guide to optimising 
medicines for patients with swallowing difficulty (Barnett and Parmar 2016). This guide is now 
being incorporated into the work of the Dysphagia and Medicines Advisory Group, led by the 
Patients Association.  
4.1.1.5 Cross-sector pharmacy communication  
The author identified from the literature that cross-sector communication was a factor in 
hospital re-admission (Witherington, Pirzada and Avery, 2008) and published an article about 
the need to improve communication at transfer of care (Barnett, 2011), highlighting patient 
and clinician issues. The author later contributed to an RPS report (Royal Pharmaceutical 
Society, 2012) describing the author’s local service and contributed to a video to illustrate 
transfer of care issues (Royal Pharmaceutical Society, 2012). Learning from the literature, 
cross–sector communication within IMMS was strengthened to include referral to the 
community pharmacy New Medicines Service (NMS) and to support discharge Medicines Use 
Review (MUR) consultations, introduced in 2011 (NHS Employers and Pharmaceutical Services 
Negotiating Committee, 2013). This was described in Barnett, Parmar and Ward (2013a) and 
later identified in the author’s work with Dr Julia Blagburn (Barnett and Blagburn, 2016). When 
referrals to NMS and MUR were initially undertaken through IMMS, referrals were written and 
faxed to the nominated community pharmacy. This yielded poor results; only 1.5% (1/65) of 
referrals resulted in a review. The change to include person-centred consultations, identifying 
what patients wanted from follow-up, as well as telephone contact with community 
pharmacists, improved referral rates  to 33% (9/28) after one month and increased to 12/28 
after a second telephone call (Barnett, Parmar and Ward, 2013a,b,c). The emphasis on good 
communication between secondary and primary care was highlighted in an audit of medicines-
related discharge information (Barnett et al., 2014), to which the author contributed 25%. This 
led to the development of discharge consultations which included discussion of the patient’s 
involvement in safer transfer of information on discharge to the next care setting. Referral 
from hospital to community pharmacy has developed nationally including establishment of an 
electronic referral system to improve transfer of care and referrals for community pharmacy 
services (Clark, 2016). Recent examples include the multiple award-winning “Refer to 
Pharmacy” service in East Lancashire (Gray, 2015), and the transfer of care project using 
PharmOutcomes in the North East of England (Nazar et al., 2016).  
57 
 
4.2 Person-centred care: A coaching approach to pharmacy 
consultations 
Health coaching was being promoted nationally to support management of long-term 
conditions in general practice as part of patient-centred care (National Health Executive, 
2015). Following training in a coaching approach to health consultations, the author published 
a personal reflection on person-centred care developed from the author’s experience of being 
prescribed a long term medicine by a General Practitioner (Barnett, 2011) . The author also 
began to use health coaching skills to develop person-centred consultations for IMMS patients.  
Pharmacy consultations at the time were commonly focussed on provision of information that 
the clinician considered important to the patient to promote safe and effective medicines use. 
A coaching approach to consultations added the patient’s perspective to the discussion, 
promoting concordant consultations through development of a partnership between patient 
and clinician. It also supported the patient in thinking about how they can make the best use of 
their medicines to improve their health and finding their own solutions to challenges around 
medicines taking and use. This “bipartite” approach to a consultation contrasted with the 
traditional “unipartite” pharmacy approach, which relied on pharmacy staff offering solutions 
to patients for medicines-related problems.  
The health coaching approach was chosen as it aligns with all four principles of the RPS 
medicines optimisation agenda (Picton & Wright, 2013), particularly supporting principle 1, 
which identifies the patient experience as a key part of medicines optimisation. In addition, a 
health coaching approach supports shared decision making, which has also been integrated 
into pharmacy services (Blagburn et al., 2016). The coaching approach was highlighted in a 
King’s Fund report (Coulter and Collins, 2011) promoting consultations which encourage a joint 
approach between clinician and patient to health-care choices. The aim of these consultations 
is to value contributions from both parties, where the patient contributes their expertise on 
their life situation, experience of illness and medicine taking and the clinician contributes their 
health expertise and experience. The first three standards of the recently revised GPhC 
Standards for Pharmacy Professionals (General Pharmaceutical Council, 2017) relate to the 
provision of person-centred care, working in partnership and communicating effectively. The 
health coaching approach can help pharmacy professionals to put these standards into 
practice and supports incorporation of shared decision making, which remains a national 
priority (NHS England, 2017).  
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4.2.1 A coaching approach to medicines adherence 
The issue of patients taking medicines as prescribed was brought to international attention 
following the WHO report on medicines adherence (World Health Organization, 2003). This 
report identified that adherence to long-term therapies in the developed world was only about 
50% and outlined factors influencing non-adherence. In the UK, Horne, Weinman, Barber et al., 
(2005) provided a national perspective and described the then current thinking around 
supporting adherence.  The author was exposed to patient perspectives on how people use 
and take medicines, through working with a multidisciplinary team, undertaking visits to 
patients’ homes with community matrons (Barnett, 2006; Jenner and Barnett, 2006;).  
Recommendation of compliance aids such as multi-compartment containers for organising 
weekly medicines into morning, lunchtime, afternoon and evening, was commonplace in the 
author’s local organisation. These were often recommended for patients who were perceived 
to have difficulty remembering to take their medicines and/or who were prescribed a large 
number of medicines. When these patients were reviewed by the pharmacy team, it became 
apparent that many requests for a multi-compartment compliance aids (MCAs) from health-
care staff were for situations not always addressed by provision of MCAs.  The literature 
highlighted potential risk of MCAs in terms of pharmaceutical stability (The Mid-Yorkshire 
Hospitals NHS Trust., 2006) and patient safety (Nunney and Raynor, 2001) while questions 
about the need for MCAs (Bhattacharya, 2005) were also highlighted. This led the author to 
develop and implement a local policy to highlight patients’ medicines support needs when 
referrals for MCAs were received. The policy focussed on the patient’s perception of their need 
for MCA support, as well as a clinical assessment (Barnett, Patel and Lam, 2007a)  and a further 
publication highlighted these issues, (Athwal, Vadher and Barnett 2011)   to which the author 
contributed 40%. The author was also involved in conversations with pharmacy colleagues 
nationally about how to approach the “MCA challenge” and this led to a publication in the 
Pharmaceutical Journal with the chair of the Care of the Elderly group for the UKCPA (Barnett 
and Taylor, 2006). This publication identified the need to use a structured method to identify a 
patient’s medicines support needs, rather than “default” to an MCA, with the risks of 
inappropriate use of these containers, such as pharmaceutical degradation of medicines. 
With the publication of NICE guidance on medicines adherence (National Institute for Health 
and Care Excellence, 2009) the author collaborated with a consultant pharmacist colleague to 
provide interpretation of the guidance (Barnett and Oboh 2009). This publication highlighted 
the importance of patient involvement in decisions about medicines and identifying patient 
beliefs about medicines to improve adherence effectively. A recent publication has 
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demonstrated a statistically signficiant correlation between medicines adherence and 30 day 
hospital readmission rates (Rosen et al., 2017). While the need for practical support with 
medicines was still evident (Anonymous, 2012) and continues to be important (Barnett and 
Goldstein, 2016), the development of health coaching as part of pharmacy practice had 
encompassed both practical and perceptual issues. A coaching approach to medicines 
adherence addressed both practical and perceptual issues through questioning and exploring 
with patients to find methods of resolving medicines-related issues. Rather than simply 
offering solutions determined by the health care professional, the coaching approach 
promoted use of the patient’s own resources to solve medicines –related problems. 
 4.2.2 The Four Es 
Working with the concept of health coaching and the author’s experience in pharmacy 
practice, the author developed a structure for short pharmacy consultations (Barnett, 2011), 
known as the “Four Es” (Explore, Educate, Empower and Enable) (see Figure 6), The author 
wrote about how this could potentially support improved medicines adherence and the risks 
to adherence when patients are disengaged (Barnett and McDowell, 2012; Barnett, 2012c,d)  
The Four Es is a structure built on the “GROW” model (Whitmore, 1992), which is widely used 
in business and performance coaching and includes four elements (Goal, Reality, Options and 
Will). This model was modified to align with pharmacy structures for consultations and was 
developed by the author into the Four Es (Barnett, N L., 2011), illustrated in Figure 6 overleaf. 
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Figure 4 The Four Es consultation structure 
 
Reproduced with permission from the Centre for Postgraduate Pharmacy Education (Centre for Pharmacy 
Postgraduate Education, 2014). 
 
The Four Es consultation structure begins with identification of the topic of conversation which 
is usually introduced by the pharmacist, contrasting with a coaching conversation where it is 
identified by the “coachee”. Rather than the commonly used method of the pharmacist telling 
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the patient what they expect the patient to want or need to know and giving safety 
information, the four Es requires the pharmacist to us the “Explore” questions (see Figure 6, 
uppermost box) to identify the patient’s agenda. The pharmacist asks about what the patient 
already knows about the medicines, what they may be concerned about and the potential 
benefits of the medicine they perceive from a health and person-centred perspective. 
Education about medicines (Figure 6, second box) is delivered in line with questions asked by 
the patient and safety information may be added in where relevant. The patient is then asked, 
using a non-judgemental approach, to consider their decision in the context of taking the 
medicine, which is highlighted by the “Empower” stage of the structure, illustrated as the 
bottom left hand text box in Figure 6. Once a decision has been made, the pharmacist supports 
the patient decision using the “Enable” questions. This is illustrated in the bottom right text 
box of Figure 6 where the pharmacist helps the patient to think about what they need to do to 
put their decision into practice and how they will maintain and monitor their chosen path.  
The Four Es should be viewed in comparison to other commonly used pharmacy consultations 
structures used in practice. While there are no standard procedures for pharmacy 
consultations, the following flow chart (Figure 7) illustrates the key features of common 
pharmacy consultations as observed in a hospital setting, for the purposes of comparison. 
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Figure 5 Flow chart to illustrate common features of a standard pharmacy consultation in a hospital 
setting. 
 
 
As an example of the application of the Four Es, an anonymised case study is presented in Box 
1 overleaf. 
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Box 1 The Four Es consultation structure: narrative of a patient consultation 
Mrs A was a patient in her mid-50s recovering from stroke. Prior to her admission she had been 
fit and well, living alone and independently. Her pre-admission prescription was for only one 
antihypertensive medicine. When the pharmacist came to discuss medicines prescribed post-
discharge, the pharmacist used a coaching approach to the consultation and asked the patient 
what she already knew about her medicines. The patient replied that she was very comfortable 
taking her antihypertensive, as she had done effectively for years. The patient said that the need 
for two weeks aspirin treatment, followed by long-term clopidogrel had been explained by ward 
staff and she was happy to take these medicines. When the pharmacist asked about the only 
other medication on the prescription, simvastatin, the patient replied that she was “less 
comfortable” about this medication. The pharmacist asked what worried the patient and the 
patient explained that she had seen a television programme, introduced by a leading medical 
professor, cautioning viewers about the side effects of “statins”. 
 
EXPLORE 
Rather than trying to persuade the patient of the benefit or need for simvastatin, the pharmacist 
tried to understand the patient’s point of view and asked the patient what she had learnt from 
the programme. The patient proceeded to explain that she understood muscle pain to be 
common and having been debilitated by her stroke, she did not want any other impediments to 
returning to normal physical function. She also mentioned that the professor had talked about 
liver damage and this was important to her as her father had died of liver cancer. 
The pharmacist showed empathy and told the patient that, given the information learnt from 
the programme, it was understandable that the patient was reticent to take a “statin”. The 
pharmacist then asked the patient if the programme had mentioned how often these side 
effects happen. The patient replied that she did not remember and the pharmacist then offered 
the patient the opportunity to look at the incidence of the side effect, which the patient 
accepted. 
 
EDUCATE 
Together the pharmacist and patient reviewed the incidence of side effects and the pharmacist 
explained the liver-related blood tests required and that the liver damage, if it occurred, was not 
linked to cancer. The pharmacist also told the patient about the incidence of muscle pain, 
acknowledging that it was common. Given the patient’s concern about physical function, the 
pharmacist recommended that should muscle pain occur, the patient could stop the medication 
and return to the GP to discuss alternative treatment. 
Finally, the pharmacist asked the patient if the programme had mentioned the benefits of using 
“statins” after a stroke. When the patient replied that it had not and that she was interested to 
learn about the benefits the pharmacist then outlined the benefits. 
 
EMPOWER 
Using the Four Es method, the pharmacist asked the patient what she now thought about the 
simvastatin, following their conversation. The patient said that she would be prepared to 
consider taking the medication for two weeks and would monitor herself for muscle pain. If it 
occurred, the patient would stop the medicine and return to the GP. If not, the patient said she 
would continue the medication and return to her GP one month after hospital discharge for liver 
function tests. 
 
ENABLE 
The pharmacist closed the consultation by asking the patient about how she would integrate the 
new medicines into her daily routine, giving the patient the opportunity to come up with her 
own ideas. The pharmacist discussed the practicalities of notifying the GP and making an 
appointment with the patient and confirmed the steps the patient would take to monitor both 
their adherence and side effects of medication. 
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While the “Enable” stage may involve discussing how, when and where a patient will take their 
medicine, it may also be used where a patient chooses not to take a medicine. In this situation 
the pharmacist can explore what the patient wishes to do to improve their health, discussing 
alternatives which may include lifestyle or diet changes. The Four Es process can be used to 
support the implementation of these changes. The author published a peer reviewed article 
including the Four Es to support medicines adherence, (Barnett, 2014) which reflected the 
current thinking around practical and perceptual approaches to adherence. 
The Four Es consultation structure has had local impact and has been taught as part of health 
coaching training in hospital and community pharmacists with ongoing anecdotal reports of 
use in practice. It is now being used in the author’s organisation by pharmacy staff trained in 
health coaching in areas such as general medicine, care of older people and HIV. The structure 
has had national impact on pharmacy consultations skills through inclusion in the CPPE 
document on consultation skills, for which the author wrote the health coaching chapter 
(CPPE, 2014). This is now being taught in university courses (King’s College London 2015/ 2016, 
2016/17, UCL School of Pharmacy 2016/17) and to postgraduate diploma students in Leeds 
(2016/17). Further developments of person-centred consultations have been published in a 
multidisciplinary journal, developing support for special groups of patients and offering a 
structured approach to patient consultations (Barnett, 2016). 
4.2.3. Person-centred consultations: collaborations 
The author collaborated on several publications to promote the use of health coaching to 
support medicines adherence. This included the publication of a peer reviewed paper (Barnett 
and Sanghani 2013) which described how the coaching approach to consultation fitted into the 
overall consultation paradigm. This was followed by an article, written with communication 
leaders and educators in pharmacy, on a practical approach to embedding person-centred care 
into pharmacy practice (Barnett, Varia and Jubraj 2013). The effectiveness of cognitive 
behavioural approaches in medicines adherence was subject to a meta-analysis (Easthall, Song 
and Bhattacharya, 2013) and, despite high heterogeneity of studies, suggested an overall 
benefit.   
The benefit of a coaching approach to pharmacy consultations was recognised within the 
author’s organisation. The author obtained a £20,000 grant from the organisation’s charitable 
fund to commission and co-deliver health coaching training for the wider pharmacy team and 
to promote the use of a coaching approach in ward, dispensary and clinic consultations.   
Positive post-course evaluation provided some evidence of perceived participant benefit and 
participant anonymised patient case studies are currently being collected for evaluation.  
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The author commented on the use of cognitive behavioural therapy as another behavioural 
technique to support medicines adherence   (Barnett, 2013b), later collaborating with a 
cognitive behavioural therapist and pharmacist. Cognitive behavioural therapy uses 
identification of patient’s thoughts, feelings and behaviours around medicines taking to help 
patients resolve issues with adherence. The author continued this collaboration and published 
an article in a nursing journal which described the potential for behavioural approaches to 
support medicines adherence for patients with cardiovascular conditions (Barnett and White 
2015). The author continued to work on development of practical approaches to person-
centred pharmacy consultations, presenting at a pharmacy technician conference and 
publishing a review of the coaching approach as it applied in pharmacy practice in the UK 
pharmacy technician journal (Barnett, 2015).  Other collaborations included a publication on 
reducing preventable medicines-related re-admission with an award-winning colleague who 
delivered person-centred pharmacy services service in a large NHS hospital trust (Barnett and 
Blagburn 2014). A further collaboration with pharmacy education leaders led to publication of 
a blog which challenged readers to consider how patient-centred their current consultations 
felt and identified time as a perceived barrier to empathy in pharmacy consultations (Barnett, 
Grimes and Jubraj 2015). This led to collaboration between the author and academic pharmacy 
and psychology colleagues, further developing the concept of empathy within pharmacy 
consultations (Jubraj et al., 2016). This publication highlighted the importance of person-
centredness to the inclusion of empathy in consultations to the pharmacy profession.  
These collaborations have developed the author’s understanding of how the pharmacy team 
can use behavioural change techniques to maximise the benefit of medicines to patients.  
Working with experts helped the author to integrate additional techniques in pharmacy-
related health coaching. Collaboration with pharmacy education colleagues highlighted the 
importance of embedding the “human” aspects of consultation early in the pharmacy career 
pathway. 
4.2.4 Polypharmacy and deprescribing: a person-centred approach 
Working with a national leader in primary care pharmacy and older people, Lelly Oboh, a 
review on the challenge of polypharmacy (Barnett and Oboh, 2014) was published. In addition, 
the author championed the need to address polypharmacy, as a central part of the provision of 
person-centred care, in another publication identifying the clinical risks of ignoring 
inappropriate polypharmacy and highlighting resources to help practitioners (Barnett, 2015c).  
The author and colleague identified that widely publicised and high-quality polypharmacy 
support documents (Duerden, Avery and Payne 2013; All Wales Medicines Strategy Group; 
2014, NHS Scotland and the Scottish Government, 2015) mainly focussed on the role of the 
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clinician in managing polypharmacy, with less emphasis on the patient perspective. Having 
incorporated a person-centred approach to medication review in the author’s practice for 
several years, the author approached a leading medicines information pharmacist, Katie Smith, 
to collaborate with Oboh and the author. Smith conducted a literature search around person-
centred medication review to manage polypharmacy and established this was poorly covered. 
Using Oboh and the author’s experience and the available literature, the group collaborated to 
develop a person-centred consultation framework for polypharmacy (Barnett, Oboh and 
Smith, 2015c), published in peer reviewed journal (Barnett Oboh and Smith, 2016). This 
framework was included in CPPE’s polypharmacy learning programme and the author 
recorded video consultations, to describe the process, for the CPPE polypharmacy media wall 
(Centre for Pharmacy Postgraduate Education, 2016). The framework has also been included in 
a summary of deprescribing for prescribers to reduce inappropriate polypharmacy (Dowden, 
2017). The author was invited to contribute a blog and deliver a keynote session on patient-
centred polypharmacy at a joint RPS and Royal College of General Practitioners conference on 
polypharmacy in April 2016 (Barnett, 2016a, b), to participate in the RPS polypharmacy 
working group (Tang, 2016) and deliver a keynote presentation to the recent Prescribing and 
Research in Medicines Management (UK and Ireland) conference (2017). 
In parallel with the issue of polypharmacy being raised by the profession, the concept of 
deprescribing was gaining momentum (Hilmer, Gnijdic and Le Couteur, 2012; Scott et al., 2015; 
Thompson and Farrell, 2013). Deprescribing can be described as the process of stopping 
medicines (Anonymous, 2014) or, more informatively, as “the process of tapering, stopping, 
discontinuing, or withdrawing drugs, with the goal of managing polypharmacy and improving 
outcomes” (Thompson and Farrell, 2013). However, as early as 2003, the importance of 
cautious reduction and cessation of medication as a collaborative effort between patient and 
clinician, was recognised  (Woodward, 2003). Success consists of minimising inappropriate 
polypharmacy and optimising deprescribing, achieved by collaboration between the clinician 
and the patient.  
The author was commissioned to co-edit a special themed deprescribing issue of the European 
Journal of Hospital Pharmacy, published in January 2017 to which the author contributed 50%. 
The author sourced a contribution from a person with multiple medical conditions, known as 
multimorbidity, and this was included in the publication to help clinicians understand the 
patient perspective (Barnett-Cormack, 2017). In addition, the author contributed to three 
publications in the themed issue (Barnett and Jubraj, 2017; Barnett and Kelly, 2017; Poots, 
Jubraj and Barnett 2017). The author contributed 25% to Poots, Jubraj and Barnett (2017). The 
themed issue was accompanied by a podcast (Soundcloud for BMJ Talk Medicine, 2016).  
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The author has also highlighted the issues of changes in the UK law which may affect 
deprescribing, where legislation about patient consent to treatment has moved towards a 
patient-focussed requirement in treatment discussion. The changes in the law are explained in 
relation to medical practice by Lee (2017) and the author published a paper (Barnett and Kelly, 
2017), in collaboration with a pharmacist who is also a medical negligence solicitor, to describe 
potential issues for deprescribing practice. A further paper with case examples has been 
accepted for publication in a widely read prescribing journal (Barnett & Kelly, 2017). The 
author has recently collaborated with Dr Daniel Sokol, a leading medical ethicist and barrister, 
publishing a paper (Barnett and Sokol 2017) to describe the potential implications of the 
recent change in the law following the Montgomery Judgement (UK Supreme Court. 
Montgomery Appellant v Lanarkshire Health Board, 2015).  This change requires clinicians to 
undertake more person-centred consultations in order to fulfil the requirements for informed 
patient consent to treatment. While support for the implications of the change in law is being 
provided for medical professionals (General Medical Council, 2015), the relevance for 
pharmacy practice has yet to be explored. This area is an opportunity for future work to 
establish “Montgomery compliant” consultations in pharmacy practice.  The author has been 
invited to contribute written guidance on the Montgomery Judgement led by the Academy of 
Medical Royal Colleges as part of the Shared Decision Making collaborative at NICE. Other 
work being developed by the author includes distribution of a pharmacy survey, working with 
an academic law colleague, to explore pharmacists’ current knowledge of the new 
developments around patient consent leading to an audit of pharmacy consultations with 
patients to assess “Montgomery compliance”.  
4.3 Implementation: Impact and Summary 
This chapter has described the author’s contribution to developing and implementing person-
centred care in pharmacy practice at local and national level. This includes the establishment 
and implementation of IMMS  which incorporates person-centred consultations as part of the 
process of delivering high quality care to patients. The national impact of the author’s work is 
demonstrated through having been invited and contributing to national publications on the 
subjects of polypharmacy and deprescribing. The author has promoted the use of person-
centred pharmacy practice in older people through delivery of presentations at national 
events. Subjects have included the specialist needs of older people, IMMS, a coaching 
approach to pharmacy consultations, medicines adherence, medication review, polypharmacy 
and deprescribing. These have been delivered to audiences at national and international 
events including the Older People Pharmacy network annual learning event, UKCPA 
conferences, British Geriatric Society conference, the annual Clinical Pharmacy Congress and 
World Organization of Family Doctors (WONCA) Europe.   The author led the IMMS team to 
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win a national award for this service (Health Service Journal, 2015). Using leadership skills to 
drive the person-centred consultation agenda forward using a coaching approach, the author’s 
has contributed to national continuing professional development. This is demonstrated 
through the author’s work with CPPE,helping to embed new approaches to consultations, such 
as the Four Es and the patient centred polypharmacy process, into everyday practice. The 
author, as joint guest editor of the publication of the European Journal of Hospital pharmacy 
themed issue, identified and commissioning a broad spectrum of contributions to this issue. 
These publications will inform and may influence Europe-wide practice through dissemination 
of knowledge in this area of practice. 
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Chapter 5. Summary, recommendations and conclusion 
5.1 Summary 
This thesis has described the author’s contribution to developing and integrating a person-
centred approach to pharmacy practice from 1997 to 2017, using examples from the author’s 
work with older people as a consultant pharmacist and prescriber. This led to innovations 
including implementation of the development of person-centred care in pharmacy practice 
through establishment of a service to reduce risk of preventable medicines-related hospital re-
admission. Integration of a coaching approach to pharmacy consultations in the author’s local 
organisation provides another example of the author’s innovation in this area. In addition, the 
author promoted the use of a coaching approach nationally to support medicines adherence, 
developing a structure for pharmacy consultations, leading to work on a person-centred 
approach to polypharmacy and deprescribing consultations. 
5.2 Impact  
The impact of the author’s work has been demonstrated locally and nationally. In the author’s 
organisation, London North West Healthcare NHS Trust, IMMS was originally provided on one 
hospital site and is now being merged with similar provision on another site and established de 
novo on a third hospital site. The new, merged service is being rolled out across the three 
hospital sites. 
The IMMS work suggests that there is a potential saving of over £3 for every £1 spent on 
employing a pharmacist to undertake IMMS work, or a return on investment (ROI) of >2  
(Barnett et al., 2017). This finding is in line but with a lower ROI with data reported from other 
IMMS sites where savings calculated including opportunity costs suggested a return of 
between £5 and £8 per every £1 spent on service provision (Scott et al., 2015). The author’s 
work has been nationally recognised through the Health Services Journal award in 2015 in the 
category of “Value and Improvement in Clinical Support Services” (Health Services Journal, 
2015).  
The combined service, known as the Pharmacy Integrated Care Service (PICS) includes all the 
key features of IMMS and the service has been rolled out to all three sites in the organisation. 
PICS provides person-centred consultations to patients, by pharmacists trained in a coaching 
approach to consultations, in hospital and after discharge to support provision of medicines-
related care across the organisation. 
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The author’s work described in this thesis has demonstrated national impact through the 
author’s involvement in NICE guideline development. The importance of person-centred 
review is enshrined in the recent NICE multimorbidity guidance (2016).  The author 
contributed to this guideline, as a member of the NICE guideline development group (2014-
2016), participating in approximately 15 meetings over 18 months to develop the guidelines 
with national expert colleagues and patients. The guideline was published in September 2016 
(National Institute for Health and Care Excellence, 2016). The author also collaborated with 
two other guideline group members to raise the profile of the guidance by publishing a 
summary of the guideline, with recommendations for practice and examples (Barnett, Payne 
and Rutherford, 2016), in a journal for prescribers. 
The author has had a national impact on the pharmacy profession through the professional 
and wider media, influencing consultation methods in pharmacy practice towards more 
person-centred consultations.  The author has promoted person-centred care to the public 
through radio interviews (Barnett, 2012a, Age UK and The Wireless Radio, 2016) and has 
contributed to various RPS professional reports (Royal Pharmaceutical Society, 2012, 2013) 
including delivering a keynote presentation (Barnett, 2016) on the patient-centred 
polypharmacy process. Consultation models, such as the Four Es and the patient-centred 
polypharmacy process, which have been solely or collaboratively created by the author, have 
been included in national educational documents for CPPE (Centre for Pharmacy Postgraduate 
Education, 2014; Centre for Pharmacy Postgraduate Education, 2016). The author’s Four Es 
model is now incorporated into UK undergraduate and postgraduate pharmacy teaching by 
the author at King’s College London and University College London and person-centred 
pharmacy consultations are being taught abroad (Cullinan, 2016). 
71 
 
5.3 Limitations 
Limitations to the author’s work are described below according to the sections to which they 
relate. 
5.3.1 Development of person-centred care working with older people.   
This is recognised to be a very broad area of practice and the author’s work has been 
necessarily limited in its scope. The author’s exposure to pharmacy practice with older people 
was limited to local work and initially as a novice researcher, was reliant on others, such as the 
author’s postgraduate MSc supervisor (Dr Sally Anne Francis) and mentor (Dr Michael 
Denham) for support in publishing work in the area for knowledge and practice. It is therefore 
possible that the work was not initially representative of pharmacy practice in older people. 
However this is mitigated by the work being underpinned by national policy and guidance 
(Royal College of Physicians of London, 1997, Department of Health, 2001) and aligned with 
published literature at the time, as described in section 3.1. In addition, the author’s 
membership of UKCPA, which has a “care of the elderly” group, allowed increased exposure to, 
and learning from, colleagues in a similar area of practice through email groups and 
conferences, posters, presentations and networking.  
The author’s work with older people is limited to a mainly hospital setting and does not 
explore how lessons learnt working with older people applies to community pharmacy 
settings. The author makes assumptions about the need for person-centred care in pharmacy 
practice and this is supported by the GPhC (General Pharmaceutical Council, 2015). In addition,  
while there is a generally a paucity of literature around the establishment of person-centred 
care in pharmacy practice, the author is not aware of literature that suggests person-centred 
care is already fully developed and embedded in other areas of pharmacy practice. 
5.3.2 Integrated Medicines Management Service (IMMS). 
This service, developed alongside other similar services in the UK, incorporates person-centred 
consultations as part of the service delivered to patients which has been shown to reduce 
preventable medicines-related re-admission. However, the pilot study had a number of 
limitations which are described in chapter 3. As a result of reflection on this, the author has 
developed a better understanding for the need for detailed and research planning in advance 
of work to be undertaken.  While the author’s earlier work was identified to be in line with 
publications at the time, collaboration with authors working in similar areas may have been of 
value in reducing or eliminating some or all of these limitations from the start.  In the later 
phases of the work, the author collaborated with a number of researchers and practitioners. 
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Challenges with data collection resulting in a lack of data continuity and lack of group matching 
from earlier work is now being addressed by use of an improved data collection tool, informed 
by tools being used at other centres, and with the involvement of a statistician at the outset of 
the new work. Expert feedback provided following submission to British Medical Journal 
publications, including Quality and Safety and European Journal of Hospital Pharmacy will be 
used to further support the improvement of future research. The author is seeking 
collaboration with an academic partner for the next phase of work.   
Development of person-centred care through IMMS is also limited by the lack of formal 
patient experience feedback. While only anecdotal feedback was received in the pilot study, 
information is currently being sought to develop a validated patient experience survey that is 
acceptable to the author’s organisation, which will be embedded within the Pharmacy 
Integrated Care Service. 
5.3.3 A coaching approach to health 
 While behavioural approaches to consultations, including health coaching, were being 
nationally promoted (Health Education England, 2015) , there was no national consensus on 
the “best” behavioural approach to use in a pharmacy setting. Different approaches would 
bring different strengths and weaknesses depending on the setting in which they were applied 
and some may be more effective than others in different settings. The author chose a coaching 
approach as it encompassed a number of behavioural approaches (Wolever et al., 2013). 
Health coaching has been used in other health settings, for example, to support lifestyle 
changes  (Olsen & Nesbitt, 2010) , and is being introduced into pharmacy practice  (Lonie et al., 
2017)  there is no published literature on the use of health coaching in hospital pharmacy 
practice, other than the author’s work. It is possible that other approaches would also have 
achieved the aim of developing person-centred care in pharmacy practice.  
A recent Cochrane Collaboration review of interventions enhancing medication adherence 
(Nieuwlaat et al., 2014) revealed that interventions were complex, with multiple components. 
Interventions were provided by allied health professionals, some of whom were pharmacists, 
and included bespoke care, education and behavioural change support techniques such as 
motivational interviewing or cognitive behavioural therapy. However, the trials reviewed 
shared no common characteristics and the few that reported improvements in adherence and 
clinical outcomes demonstrated only a small effect. The COM-B model (Michie, van Stralen and 
West, 2011) describes behaviour change methods applied to medicines adherence (Jackson et 
al., 2014) but there is no consensus as to the optimal behavioural change method.  
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The use of health coaching to support person-centred care aligned with the Cochrane 
Collaboration review of the key elements of patient-centred care (Dwamena et al., 2012 ). 
Health coaching has been used to improve health in a number of areas, such as weight 
management,  improving physical activity, as well as medication adherence, suggesting that 
this behavioral intervention is effective in improving health behaviours including around 
medicines  (Olsen and Nesbitt, 2010 ). The author collaborated with pharmacy and health 
psychology colleagues to decide upon the choice of a singular approach but is mindful that no 
approach has been proven to be successful. It is possible that multiple approaches may be 
more effective, but evidence is lacking. 
Emerging evidence suggests that improving medicines adherence can contribute to reducing 
30-day hospital readmissions (Rosen et al., 2017) and the benefits of health coaching to 
medicines adherence had been identified both in trials (Thom et al., 2015; Wolever and 
Dreusike 2016) and through reviews   (Olsen and Nesbitt, 2010; Anonymous, 2014a), which 
lends some validity to its use. However, there continues to be a paucity of robust data in the 
area and a recent systematic review by the Cochrane collaboration in 2014 (Nieuwlaat et al., 
2014) concluded that existing studies varied so widely that they could not be combined 
through statistical analysis to deliver conclusions about ways to improve medicines adherence. 
This conclusion has been supported by a more recent review (Marcum, Hanlon and Murray. 
2017). 
5.3.4 Polypharmacy and deprescribing 
This is an emerging area of practice and there are currently no nationally approved, evidence 
based consultations models. While there are no large trials of polypharmacy and deprescribing 
tools tested in practice (Scott, Anderson and Freeman, 2017), smaller studies have shown 
efficacy of models, for example, the Good Palliative Geriatric Algorithm (Garfinkel, Zur-Gil and 
Ben-Israel., 2007). The collaborative process, co-authored with colleagues Katie Smith and Lelly 
Oboh, was tested by Lelly Oboh in a community setting in South London in 82 patients (Smith, 
Oboh and Barnett, 2016) showing that the model could be used in a community setting for 
polypharmacy medication reviews. However, it is recognised that this model not yet been 
tested in the hospital environment.  The robustness of the model comes from its foundation in 
well-researched, published national guidance.  
The author’s involvement in deprescribing and the implications of new case law is an emerging 
area of work and implications are yet unknown. Collaboration with pharmacy and legal expert 
colleagues is intended to help to develop stronger arguments to support the safety of 
deprescribing. 
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5.4 Recommendations 
5.4.1 Supporting specific patient groups. 
 The author’s work with older people provided the author with an insight into specific groups 
of patients where a person-centred approach can improve pharmacy practice (Barnett, N., 
2016). This included people with physical impairment, speech impairment and swallowing 
difficulty. The author developed national learning events to explore the contribution of 
pharmacists to specific patient groups. This included the development of the tool, in the form 
of a set of slides, to support people with aphasia in consultations about anticoagulants 
(Bhandal, Barnett and Clarkson., 2016). Another learning event led to the development of a 
flow chart to help pharmacists and nurses optimise medication for patients with swallowing 
difficulty (Barnett and Parmar, 2016). Both of these resources benefited from collaboration 
with experts including speech and language therapy colleagues, a consultant pharmacist in 
anticoagulation and a lead pharmacist for stroke services within the author’s organisation, 
which houses a nationally leading stroke service. The author is currently continuing this theme 
of work, through collaboration with the Royal National Institute for Blind People (RNIB) and 
Moorfields Eye Hospital, to develop person-centred medicines-related care for people with 
sight loss. 
5.4.2 Reducing risk of preventable medicines-related re-admission. 
 The IMMS work is now being rolled out across the author’s local organisation across all three 
hospital sites within the trust, evolving into the Pharmacy Integrated Care Service (PICS), which 
will provide pharmacy support in an equitable way across the author’s organisation. Working 
with expert colleagues the author is developing a more robust data set for use within PICS. 
This will include recording of patient demographics, co-morbidities and classifying re-
admissions using the PREVENT© criteria, aligned with the tool used to identify patients on 
admission to the service. The PICS team are reviewing methods of embedding exploration of 
patient experience in the service. The service will provide a standardised training programme 
for all pharmacy staff, including in how to conduct person-centred consultations, as well as a 
standard procedure for PICS activity. Training for clinical staff that can refer patients to PICS 
will be conducted through a rolling programme for specific staff groups, for example, 
occupational therapists, nurses and junior doctors. Future development may include 
collaboration with other centres delivering similar services such as the Northumbria 
Healthcare SHINE project (Baqir et al., 2014   ) , Newcastle Hospital’s MAGIC programme 
(Health Foundation, 2013; Blagburn et al.,2016, ) and the Lewisham LIMOS service (Lai et al., 
2015). These services have shown benefit in reducing medicines-related problems and re-
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admission. It is hoped that collaboration will lead to publications and develop national 
recommendations for all hospital trusts to provide similar services to patients. 
5.4.3 A coaching approach to consultations  
The current focus of the author’s coaching- related approach to consultations involves patient-
facing pharmacy staff within the author’s organisation in order to embed the approach into 
everyday practice. Working with local clinical pharmacy colleagues, the author is currently 
developing a consultation structure, using a coaching approach, which aligns with the 
processes of medicines reconciliation, medication review and discharge consultations on a 
hospital ward. The next steps may include working with colleagues outside the hospital 
environment to develop bespoke consultations structures that meets the needs of both 
patients and organisations. The long-term aim is to work with national organisations 
supporting skill development in a coaching approach for patient-facing pharmacy staff in all 
sectors of practice. 
5.4.4 Leadership 
While the author is no longer practicing as pharmacist prescriber, the author continues to lead 
the consultant pharmacist group in the UK, developing a strategy with the RPS to increase 
equitable provision of consultant pharmacist support for patients in the NHS.  On completion 
of this doctorate, it is the author’s intention to demonstrate that a PhD by publication, 
currently uncommon in pharmacy practice, is both possible and beneficial in terms of further 
development of research skills for experienced pharmacy practitioners. The author, in 
collaboration with the author’s pharmacy supervisor and the professional development and 
support lead at the RPS, intends to publish a paper describing the various routes for senior 
practitioners to develop their research skills, including a description of the author’s journey 
towards attainment of a PhD by publication. 
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5.5 Conclusion  
This thesis demonstrates that the author has contributed to the development of person-
centred care in pharmacy practice. Evidence to support this conclusion includes the author’s 
development of person-centred care working in pharmacy practice with older people, the 
development and use of leadership skills as a consultant pharmacist and as a pharmacist 
prescriber as well as pioneering the use of health coaching in pharmacy practice. The author 
has established an award-winning local service which incorporates person-centred 
consultations. Nationally promoting the use of coaching-based, structured, person-centred 
pharmacy consultations, the author has advocated for person-centred medication review and 
contributed to improving medicines adherence, reducing inappropriate polypharmacy and 
optimising safe deprescribing. These contributions to development of person-centred care in 
pharmacy practice support medicines optimisation, improving the patient experience and the 
provision of safe, effective pharmacy services, embedded in everyday pharmacy practice. 
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7 Appendices  
7.1 Appendix 1: Literature search terms 
MeSH terms:  aged, pharmacy service, hospital (includes clinical pharmacy service) patient-
centered care, medication adherence, 
EMBASE terms: Patient centred care, collaborative care, patient focussed care, Pharmacy 
practice, pharmaceutical care, medicines management, medicines optimisation Older people , 
elderly, geriatrics, aged, older people, in-patients hospital Clinical Pharmacy Service, In-
patients, Patients, Pharmaceutical care = pharmaceutical service pharmacists. 
Additional terms considered from exploded keywords, terms from references identified:  
Person centred, patient centred, people centred care, old, older, elderly , aged, geriatrics, 
“pharmacy practice”, “pharmaceutical care”, “medicines optimisation”, “drug management”, 
“medicine  management”, “medication review” "health coaching" “patient empowerment” 
“patient activation”  “shared decision making” “ empathy”  
 
NICE evidence 2.2.17 Database(s) Search Term   
1AMED, BNI, CINAHL, EMBASE, HBE, HMIC, Medline, PsycINFO, PubMed(((patient OR people 
OR person) AND (centred OR centred)) AND care).ti,abView Results (23,446)Edit 
2AMED, BNI, CINAHL, EMBASE, HBE, HMIC, Medline, PsycINFO, PubMed("pharmaceutical 
care" OR "pharmacy practice" OR "medicines optimisation" OR "pharmacist").ti,ab 
View Results (74,599)Edit 
3AMED, BNI, CINAHL, EMBASE, HBE, HMIC, Medline, PsycINFO, PubMed(old OR older OR aged 
OR elderly OR geriatric).ti,abView Results (9,960,571)Edit 
4AMED, BNI, CINAHL, EMBASE, HBE, HMIC, Medline, PsycINFO, PubMed(((((patient OR people 
OR person) AND (centred OR centred)) AND care) AND ("pharmaceutical care" OR "pharmacy 
practice" OR "medicines optimisation" OR "pharmacist")) AND (old OR older OR aged OR 
elderly OR geriatric)).ti,ab    Results (23) 
Allied and Complementary Medicine (AMED)British Nursing Index (BNI), Cumulative Index of 
Allied and Nursing Health Literature (CINAHL) Excerpta Medica (EMBASE), Health Business Elite 
(HBE) Health Management Information Consortium (HMIC) , Medline and PubMed  (general 
medical databases) Psychology and allied fields (PsychInfo)  
  
OVID 2.2.17 
International Pharmaceutical Abstracts 1970 to January 2017,  Social Policy and 
Practice 201701 
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 ((patient or people or person) and (centred or centred) and care and ("pharmaceutical care" 
or "pharmacy practice" or "medicines optimisation" or "pharmacist") and (old or older or aged 
or elderly or geriatric)).mp. [mp=ti, hw, rw, ab, tn, pt, an] Results 2 
Example of where author’s work contributed 
 OVID Embase medline psychoinfo social policy and practice International pharmaceutical 
abstracts 
1. (patient or people or person) and (centred or centred) and care). 18351 
7. "pharmaceutical care" or "pharmacy practice" or  "medicines optimisation".  36173 
3. older or aged or elderly or geriatric 9067941 
10. (medication or medicine or medicines) and review) 448800 
33. “health coaching” 796 
1 and 3 and 7 = 26 
7 and 33= 4 3 are the same one by me 
 “health coaching” and “pharmacy” 32 (2 by the author) 
2.  ((medicine or medication or medicines) and (adherence or compliance)) 119838 
3.  "health coaching" 724 
 4. (pharmacy or pharmacist). 274460 
2 and 3 and 4  = 16 
 Remove duplicates 9 (2 papers are mine) 
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7.2 Appendix 2 Iterations of structure 
First iteration: chronological, linking health professional and pharmacy activity with author’s 
activity, outputs and impact 
 
Key: Centre for Pharmacy Postgraduate Education (CPPE) Department of Health (DH) General Pharmaceutical 
Council (GPhC) Integrated Medicines Management Service (IMMS) Medicines use review (MUR) Multidisciplinary 
team  (MDT) National Institute for Health and Care Excellence (NICE) National service framework (NSF) New 
medicines service (NMS) Older people (OP) Royal college of Physicians (RCP) Royal Pharmaceutical Society (RPS) 
Shared Decision Making (SDM) World Health Organisation (WHO) 
 
 
Potential 
chapter 
headings:  
Health professionals 
and pharmacy 
activity 
Author’s activity  Outputs and 
Impact 
Introduction What is person-
centred care, why 
important 
What is pharmacy 
practice, breadth, 
my focus 
Brief history of hospital pharmacy practice to give 
context. What did I identify that was missing from 
pharmacy practice and what was the patient perspective 
on health care? 
  
Methodology What methods were 
used in papers 
What did I use? Literature review, observation of current 
practices (literature and direct), identification of 
professional standard for pharmacy. What were other 
profs doing. How could this apply to pharmacy? Gaps 
and how to fill them (what can we take from others into 
our practice?) 
  
1980s and 90s Development from 
ward to clinical 
pharmacy 
Geriatrics, therapies 
and medicine 
activity 
Link to community 
pharmacy. 
Clinical to specialist 
pharmacy 
Development of 
person centred care 
outside pharmacy 
What did I identify -  over-the-counter medicines, clinical 
approach compared to person centred team approach 
MDT on the geriatric wards, holistic care, ward round 
(junior pharmacist role) person centred care in medicine 
Primary care and medicines information experience, 
academic (MSc/ diploma). 
Focus on older people speciality with holistic view 
OP- related 
articles, work 
with 
universities on 
modules for 
older people 
4 2000s NSF for older people 
document, RCP 
document.  
Focus on pharmacy 
input, medication 
review, prescribing 
specialism of OP. 
Adherence who 
2003 
Need for clinical and communication (referenced in 
publications. Model effective behaviours on published 
successes, OP project, medicines reconciliation, 
medication review, consultation and communication. 
Interface support, person-centred, holistic, clinical care 
OP Services 
developed, 
prescribing 
services, RPS 
prescriber 
work, 
mentoring, 
communication 
Pharmacy case 
studies (book) 
5 2010s Prescribing in 
general  practice, 
Patient-focussed 
care (community 
and hospital) 
National imperative 
long term conditions 
and self 
management 
Use in all sectors including community domiciliary, general practice, 
clinics, hospital prescribing. 
National roles, national publications, supporting national organisations, 
papers on coaching, behaviour change, integrating into routine pharmacy 
practice pharmacy and others. Behavioural change to support medicines 
optimisation integrated into postgraduate, undergraduate and 
prescribing competencies. Person-centred concept introduced into 
polypharmacy, deprescribing. 
6 Summary, 
recommend-
ations 
Patient facing clinical care – medicines optimisation, included in all undergradate programmes, 
research needed to optimise efficacy of training and matching skills to roles person-centred to 
collaborative to patient perspective care. 
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Notes: Explain all the key terms in introduction, key documents, what is person-centred care, 
what is pharmacy practice (UK and international models where philosophy of care is similar), 
why important breadth, my focus. Provide brief history of hospital pharmacy practice to give 
context.  Include what did I identify that was missing from pharmacy practice - patient 
perspective on health care? Methods Qualitative, action research based, dialogic collaborative 
praxis 
 
Third iteration 
 
Introduction: 
Person-centred 
care, pharmacy 
practice, older 
people 
Pharmacy practice 
working with 
older people 
Development of 
pharmacy practice 
1997 to date 
Medicines optimisation 
challenges and models of 
care 
Development of a person-
centred approach 
Literature/ 
national 
documents 
Definition of 
person-centred 
care, pharmacy 
practice, 
context of older 
people. 
Use  WHO docs, 
link to UK 
bodies and 
definitions 
in similar 
philosophies of 
care US, 
Canada, 
Australia 
Key docs incl. RCP, 
NSF Spoonful of 
sugar.  MDT 
working, med 
review, cross 
sector working, 
development 
of intermediate 
and integrated 
care 
Journey through 
ward, clinical, 
prescribing 
pharmacy practice, 
Community 
medication review 
(MUR/NMS), newer 
patient facing work 
for general practice-
based pharmacists 
Polypharmacy, 
multimorbidity, 
deprescribing, 
medicines adherence 
Shared decision making, 
Self- care, behaviour 
change. Supported by 
health foundation King’s 
fund, DH. National 
documents, Five yearr 
forward view 
with pharmacy and national 
documents preceding them. 
My 
contribution  
and Ideas 
Publications 
about older 
people. Idea 
Publications 
developing clinical 
and 
Publishing consultant 
practice in pharmacy 
(pharmacy leaders), 
Publishing to help put 
above in practice 
developing national 
Second iteration 
 
 Summary of evidence to support my contribute to the development of Person-centred Care in 
Pharmacy Practice 
 Introduction: 
Person-centred 
care, pharmacy 
practice, older 
people 
Pharmacy practice 
working with older 
people 
Development of 
pharmacy 
practice 1997 to 
date  
Challenges to 
medicines 
optimisation in 
pharmacy 
practice 
Development 
of a person-
centred 
approach – 
models of 
care 
Literature 
/national 
documents 
Definition UK 
and similar 
philosophies of 
care world 
health 
organisation, 
US, Canada, and 
Australia? 
RCP and  NSF 
Spoonful of sugar, , 
medication review, 
cross sector, 
intermediate and 
integrated care 
Ward, clinical, 
prescribing, 
community 
pharmacy 
medication 
review, General 
practice-based 
pharmacists 
Polypharmacy, 
multimorbidity, 
deprescribing, 
meds adherence 
 SDM, Self 
care, 
behaviour 
change, 
Health 
Foundation,  
King’s fund, 
DH drive 
My 
contribution  
and Ideas 
generated for 
practice 
Idea from 
medicines to 
move into 
pharmacy. 
Pharm as part of 
MDT, 
collaborative 
working 
Developing clinical 
and communication 
practice. Patient life 
outside health and 
clinical focus 
leaders 
consultant 
practice, OP 
curriculum, 
interface work 
MUS NMS in 
community 
pharmacy. 
Developing a 
person-centred 
approach 
National thinking 
for pharmacy (all 
above). How to 
change pharmacy 
practice to 
patient-centred 
practice 
Coaching 
approach to 
consult-
ations, 
empathy in 
pharmacy 
practice 
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generated 
for practice 
from medicine 
(geriatrics) to 
move into 
pharmacy.  
Pharmacy as 
part of MDT, 
 collaborative, 
cross sector 
working 
communication 
practice in 
parallel. 
Considering the 
patient life 
outside the 
traditional 
(medicines) health 
and clinical focus 
prescribing, 
developing older 
people  
curriculum (RPS), 
new models of care 
and interface work 
Developing a person-
centred approach, 
thinking for pharmacy (all 
above). Publishing support 
for how to change 
pharmacy practice to 
patient- centred 
practice. Coaching 
approach to consultations, 
empathy in pharmacy 
practice work with CPPE, 
DH, NICE 
 
 
 
Fourth iteration after discussion with the author’s supervisors 
 
 Introduction: 
Person-centred 
care, pharmacy 
practice, older 
people 
Publications 
about older 
people. Geriatrics 
to Pharmacy as 
part of 
multidisciplinary 
team 
collaborative, 
cross-sector 
working 
Literature 
from 
Pharmacy 
and national  
context 
Pharmacy practice 
working with older 
people, RCP, NSF 
Leadership in 
pharmacy practice 
1997 to date: new 
consultant and 
pharmacist prescribing 
roles 
Medicines optimisation through 
medicines adherence and health 
coaching, supporting patients at 
risk of preventable medicines-
related re-admission, 
medication review, 
polypharmacy and 
deprescribing 
My 
contribution  
and Ideas 
generated 
for practice 
Publications 
developing clinical and 
communication 
practice in parallel. 
Considering the patient 
life outside the 
traditional 
(medicines) health and 
clinical focus 
Publishing consultant 
practice in pharmacy 
(pharmacy leaders), 
prescribing, developing 
older people  
curriculum (RPS), new 
models of care 
and interface work 
Developing a person-
centred approach, 
Publishing to help put above in 
practice developing national 
thinking for pharmacy (all 
above). Publishing support for 
how to change pharmacy 
practice to pt. centred 
practice. Coaching approach to 
consultations, empathy in 
pharmacy practice work 
with CPPE, DH, NICE 
 
 
Fifth iteration following review of health-related PhD by publication 
 Introduction: 
Explain Person-centred care, 
pharmacy practice, older 
people 
Outline publications that 
influenced practice Geriatrics 
to Pharmacy as part of 
multidisciplinary team 
collaborative, cross-sector 
working 
Methodology: 
explanation of 
methods used 
in various 
publications 
and how these 
methods were 
fit for purpose, 
with examples 
of where used 
in my work 
Developing skills in 
Pharmacy practice: Older 
people -  Considering the 
patient life outside the 
traditional 
(medicines) health and 
clinical focus, learning 
leadership skills to later take 
forward person-centred 
work in pharmacy 
 
Medicines optimisation through: 
 Compliance aids to medicines 
adherence and health coaching  
Coaching approach to consultations, 
empathy in pharmacy practice work 
with CPPE, DH, NICE. Medication 
review and supporting patients at risk 
of preventable medicines-related re-
admission, polypharmacy and 
deprescribing. Publishing to help put 
above in practice developing national 
thinking for pharmacy (all above) 
Publishing support for how to change 
pharmacy practice to patient- centred 
practice. 
Literature from Pharmacy 
and national context (DH, 
RCP, NSF, WHO etc). Put into 
context what I contributed 
and Ideas generated for 
practice. State aims and 
objectives 
Action research 
Document 
analysis 
Dialogue 
Collaborative 
Praxis 
Quantitative 
pilots 
Older people (clinical, 
curriculum) 
In-patient and intermediate 
care 
Consultant (leadership) 
Prescriber (new 
consultations) 
  
Describe new models of care 
and interface work  
Developing a person-centred approach 
through coaching 
Developing pharmacy work through 
patients at risk of preventable 
medicines-related re-admission, 
Combining the two in the 
polypharmacy and deprescribing work 
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Sixth iteration following discussion with pharmacy project manager 
 
Introduction: Methodology: Development: Implementation: Impact: 
Explanation of 
Person-centred 
care, pharmacy 
practice, older 
people 
Outline 
publications that 
influenced practice 
Geriatrics to 
Pharmacy as part 
of multidisciplinary 
team 
collaborative, 
cross-sector 
working 
Explanation of 
methods used in 
various 
publications and 
how these 
methods were 
fit for purpose, 
with examples 
of where used 
in my work 
Clinical, 
communication, 
leadership, 
education 
Clinical skills and 
considering the 
patient life outside 
the traditional 
(medicines) health 
and clinical focus, 
learning leadership 
skills to later take 
forward person-
centred work in 
pharmacy. 
 
Local: supporting 
patients at risk of 
preventable 
medicines-related re-
admission (integrated 
medicines 
management service, 
IMMS), 
National :Coaching 
approach to 
consultations, 
empathy in pharmacy 
practice work 
polypharmacy and 
deprescribing 
Publishing to help put 
above in practice 
developing national 
thinking for pharmacy 
(all above) 
Publishing support for 
how to change 
pharmacy practice to 
patient-centred 
practice. 
Local: changes to local 
processes 
National: contribution 
to DH, NICE , CPPE, 
RPS. National and 
international 
publications and 
conferences. Change 
to practice. 
Recommendations 
with guidelines e.g. 
prescriber guidelines, 
GPhC, RPS, 
consultations skills 
frameworks 
Literature from 
Pharmacy and 
national context 
(DH, RCP, NSF, 
WHO etc). Put into 
context what I 
contributed and 
Ideas generated 
for practice. State 
aims and 
objectives 
Method include: 
Action research 
Document 
analysis 
Dialogue 
Collaborative 
Praxis 
Quantitative 
pilots 
Older people 
(clinical, leadership, 
education) 
In-patient and 
intermediate care, 
including medication 
review(clinical) 
Consultant 
(leadership) 
Prescriber 
(leadership, 
education) 
Medicines 
adherence, med 
review, health 
coaching 
(communication, 
education) 
Link all 3 
deprescribing, 
polypharmacy 
IMMS patients local 
pharmacy work 
reducing at risk of 
preventable 
medicines-related re-
admission, describe 
new models of care 
and interface work 
coaching, person-
centred approach 
through use within 
IMMS, teaching, CPPE, 
DH, NICE 
Medication review 
using a coaching 
approach to 
polypharmacy and 
deprescribing 
Combining clinical, 
communication and 
using leadership and 
education to develop 
coaching, 
polypharmacy and 
deprescribing work.  
Cross discipline work 
to spread message, 
collaboration outside 
health (deprescribing, 
law) 
Summarise 
comparison of 
author’s work to 
existing work in the 
area and highlight 
contributions and 
challenges from other 
published work and 
author’s own work. 
Describe 
recommendations for 
future work. 
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9 Key publications supporting this thesis  
This section offers the reader a selection of the author’s publications referred to Chapters 1-5 
of this thesis. The publications are arranged according to the themes described in Chapters 3 
and 4, to provide evidence of the author’s contribution to developing a person-centred 
approach to pharmacy practice. The publications have been reproduced in full and may be 
viewed on the credit card USB drive, found in the plastic pocket at the end of this thesis, 
together with video and audio files.   
Older people  
Denham M and Barnett N.L.  Drug Therapy and the older person - The role of the pharmacist. 
Drug Safety 1998 Vol 19 No 4 p243-250 
Barnett N and Francis SA 2002 National Service Framework for Older People: The role of the 
pharmacist, pilot study. Final Report.  
Barnett N.L. Taylor D. Care of the Elderly – How pharmaceutical care has developed. Hospital 
Pharmacist 2004 vol11 p225-230  
Bowyer, C. & Barnett, N., 2005. Does the HOMER trial signal the end for pharmacist medication 
reviews?. Pharmaceutical Journal, Volume 274, p. 620. 
*Barnett, N. L., , D. & Bowyer, C., 2007. Making medication reviews work for patients. Rapid 
response to Salter C et al. British Medical Journal, p. doi:10.1136/bmj.39171.577106.55 
(published 20 April 2007).  
Barnett N and Oboh L. A new medication review guide from NPC Plus and the Medicines 
Partnership will benefit both pharmacists and patients. Pharmacy in Practice. March/April 
2009 p53-54  
Impact of prescribing 
Barnett N. Nonmedical prescribing for patients in long term care. Prescriber. 2007;18;23-24  
Barnett N. Prescribing on the wards – is it coming of age? Hospital Pharmacist 2008:15:234  
Consultant role 
Barnett N. “Consultant Pharmacist.”- What does it mean? Hospital Pharmacist 2008;15:34  
Mason J,  Stephens M and Barnett N. Releasing the potential of consultant pharmacists in the 
new NHS arena. Pharmaceutical Journal 2010;28:467  
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Local implementation: Integrated Medicines Management Service 
(IMMS) 
Fertleman M, Barnett NL, and Patel T. Improving medication management for patients:  The 
effect of a pharmacist on post-admission ward rounds. Quality and Safety in Health Care 2005 
vol14 
Athwal D, Barnett NL and Rosenbloom EK. Medicines-related admissions: you can identify 
patients to stop that happening. Pharmaceutical Journal 2011;286:471-2    
Barnett, N. & Blagburn, J., 2016:. Reducing preventable hospital admissions: A way forward. 
Clinical Pharmacist , 8(1), p. DOI: 10.1211/PJ.2016.20200365. 
Barnett, N., Parmar, P. & Ward, C., 2013a. Supporting continuity of care: referral to the NMS 
after discharge from hospital. Pharmaceutical Journal Volume 290, p. 178. 
Barnett NL Dave K Kaher S Parmar P and Ward C. Impact of integrated medicines management 
services (IMMS) on preventable medicines-related re-admission to hospital: A descriptive 
study. European Journal of Hospital Pharmacy 2016 doi:10.1136/ejhpharm-2016-000984  
National implementation 
Medicines adherence 
Barnett N and Oboh L. Interpreting guidance on medicines adherence.  British Journal of 
Clinical Pharmacy 2009:1:283 
Barnett NL. Adherence: A taste of my own medicine. Pharmaceutical Journal 2011:287:201  
Barnett N Varia S and Jubraj B. Adherence: Are you asking the right questions and taking the 
best approach? Pharmaceutical Journal 2013;291:153  
Coaching 
Barnett, N. L., 2011. The new medicines service and beyond – taking concordance to the next 
level. Pharmaceutical Journal, Volume 287, p. 653. 
Barnett, N. & Sanghani, P., 2013. A coaching approach to improving concordance. International 
Journal of Pharmacy Practice, 21(4), p. 270–272. 
Barnett N. 2015 Patient centred consultations to support medicines adherence: a coaching 
approach. Pharmacy Technician Journal. September p 28-29 
In Consultation skills for pharmacy practice: taking a patient-centred approach Chapter 5 
Health Coaching March 2014 Centre for Postgraduate Pharmacy Education  
 
Empathy 
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Jubraj B, Barnett NL, Grimes L, Varia S, Chater A, and Auyeung V. Why we should understand 
the patient experience: clinical empathy and medicines optimisation. International Journal of 
Pharmacy Practice Article first published online: 21 APR 2016 | DOI: 10.1111/ijpp.12268   
Polypharmacy 
Barnett NL Oboh K and Smith K. Patient-centred management of polypharmacy: a process for 
practice Eur J Hosp Pharm ejhpharm-2015-000762Published Online First: 23 December 
2015doi:10.1136/ejhpharm-2015-000762  
Deprescribing 
Barnett N and Sokol D. Why pharmacists need to re-evaluate what information they provide to 
patients The Pharmaceutical Journal, Vol 298, No 7897, online | DOI: 
10.1211/PJ.2017.20202226 (accessed 6.2.17) 
Barnett N, Jubraj B. A themed journal issue on deprescribing. Eur J Hosp Pharm January 2017 
Vol 24 No 1p 1-2  
Barnett, N. & Kelly, O., 2017. Legal implications of deprescribing: a case scenario. Prescriber, 28 
March, Volume March, pp. 49-52. 
Multimorbidity 
Barnett, N., Payne, R. & Rutherford, A., 2016. NICE multimorbidity guideline: coping with 
complexity in care. Prescriber, 27(12), pp. 41-46. 
Specialist support 
Bhandal S Barnett N and Clarkson K. Development of an aphasia-friendly warfarin consultation 
tool for patients after stroke. British Journal of Neuroscience Nursing 2016;12(3):112-117 
Barnett N Parmar P. How to tailor medication formulations for patients with dysphagia. 
Pharmaceutical Journal 2016:297:7892 published online 23 Aug 2016 
Barnett NL Improving pharmacy consultations for older people with disabilities. Journal of 
Medicines Optimisation 2016:2(4) p 72-76  
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Links to multimedia content 
Audio 
1. Barnett N and Jubraj B. 2016.  BMJ talk medicine. Deprescribing: a special issue from the 
European Journal of Hospital Pharmacy Podcast. 
https://soundcloud.com/bmjpodcasts/deprescribing-a-special-issue-from-ejhp 
 
2. Barnett N and Fattah L. 15 June 2016a. Agenda with Martyn Lewis: Polypharmacy. 
http://www.thewirelessradio.com/templates/radio/console/index.aspx?feature=c29af761-
27f6-49bc-be5b-ee232fa98751&url=http%3a%2f%2fwww.thewirelessradio.com%2fradio-rss-
feed%2f%3ffeature%3dc29af761-27f6-49bc-be5b-
ee232fa98751&homepage=http://www.thewirelessradio.com/&radioPlayerPageID=185 0 min 
to 18mins 
 
3. Barnett N and Grimes L. 21 Sept 2016.  Agenda with Martyn Lewis: Getting the most from 
your appointment time.  
http://www.thewirelessradio.com/templates/radio/console/index.aspx?feature=3d2b1827-
56ab-46c7-b80a-307df0fcf56e&url=http%3a%2f%2fwww.thewirelessradio.com%2fradio-rss-
feed%2f%3ffeature%3d3d2b1827-56ab-46c7-b80a-
307df0fcf56e&homepage=http://www.thewirelessradio.com/&radioPlayerPageID=185 23 
mins to 43 mins 
Video 
4. Post discharge consultation. Stroke Pathway.  Imperial College London. 2014.  
https://vimeo.com/78354273 
5. Barnett N and Jubraj B. Centre for Pharmacy Postgraduate Education. 2015. What would be 
helpful to you right now:  
5a. Making a difference in a short consultation. 
https://www.youtube.com/watch?v=_fOSMjHikqw 
5b. Making a difference in a short consultation debrief. 
https://www.youtube.com/watch?v=sW7j5PK946M 
6.  Centre for Pharmacy Postgraduate Education (CPPE) Polypharmacy media wall. 2016. 
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